syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	1.333333	100.0
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.1343874	85.07907626976906
HEPATOCELLULAR CARCINOMA	1.0833333	81.25001781250445
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.05504124	79.1281127820282
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0434783	78.26089206522302
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0434783	78.26089206522302
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	1.03365964	77.52449238112308
HEPARIN-INDUCED THROMBOCYTOPENIA	1.03125	77.34376933594233
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.0232468600000002	76.74353368588343
TRANSSEXUALITY	1.0172414	76.29312407328102
LOWRY-MACLEAN SYNDROME	1.0120482	75.90363397590848
SPLENOPORTAL VASCULAR ANOMALIES	1.01105972	75.82949795737449
WILSON DISEASE	1.00869565	75.65219266304815
MEVALONIC ACIDURIA; MEVA	1.00729475	75.54712513678128
PREECLAMPSIA	1.00670335	75.50277012569254
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00342466	75.25686831421707
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.00240964	75.18074179518544
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.00240964	75.18074179518544
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	75.00001875000468
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	75.00001875000468
AGENESIS OF CEREBRAL WHITE MATTER	1.0	75.00001875000468
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	1.0	75.00001875000468
AUTOIMMUNE HEPATITIS	0.79439272	59.579468894867226
AICARDI-GOUTIÈRES SYNDROME	0.73574264	55.18071179517795
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.7	52.50001312500328
PHEOCHROMOCYTOMA	0.7	52.50001312500328
SLC35A2-CDG	0.6467283399999999	48.50463762615939
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.5434783	40.76088269022067
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	40.17858254464563
THROMBOCYTOPENIA 1	0.5333330000000001	39.99998499999625
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.53125	39.84375996093999
AICARDI-GOUTIERES SYNDROME 5	0.52250949	39.188221547055385
MOWAT-WILSON SYNDROME; MOWS	0.5222675099999999	39.170073042518254
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.50943396	38.207556551889134
JUVENILE POLYPOSIS SYNDROME	0.50826446	38.11984402996101
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.50729475	38.04711576177894
GITELMAN SYNDROME	0.50613497	37.960132240033055
MATTHEW-WOOD SYNDROME	0.50549451	37.91209772802443
GRAFT VERSUS HOST DISEASE	0.50401606	37.801213950303485
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.50401606	37.801213950303485
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	37.50000937500234
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.5	37.50000937500234
FAMILIAL DILATED CARDIOMYOPATHY	0.5	37.50000937500234
BILATERAL POLYMICROGYRIA	0.5	37.50000937500234
INHERITED CREUTZFELDT-JAKOB DISEASE	0.5	37.50000937500234
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	37.50000937500234
AGEL AMYLOIDOSIS	0.5	37.50000937500234
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.5	37.50000937500234
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.5	37.50000937500234
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	37.50000937500234
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.5	37.50000937500234
BRANCHIOOTORENAL SYNDROME 1	0.5	37.50000937500234
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.5	37.50000937500234
HSD10 DISEASE	0.47619	35.71425892856473
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.45	33.75000843750211
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.44730906000000004	33.54818788704697
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.4242421	31.818165454541365
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.4242421	31.818165454541365
SCHWARTZ-JAMPEL SYNDROME	0.41016885999999997	30.762672190668045
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.4065655	30.49242012310503
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.37697369999999997	28.273034568258637
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.3768113	28.260854565213638
HYDROXYKYNURENINURIA	0.3768113	28.260854565213638
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.36111099999999996	27.083331770832935
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.3565655	26.742419185604792
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33712088	25.28407232101808
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33675766	25.256830814207703
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.33574264	25.18070429517607
20Q13.33 MICRODELETION SYNDROME	0.33574264	25.18070429517607
PROGEROID SYNDROME, PETTY TYPE	0.333333	24.999981249995308
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.333333	24.999981249995308
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.333333	24.999981249995308
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.333333	24.999981249995308
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333333	24.999981249995308
DANDY-WALKER SYNDROME	0.333333	24.999981249995308
IMMUNE DEFICIENCY DISEASE	0.333333	24.999981249995308
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.333333	24.999981249995308
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	24.999981249995308
NEUROMYELITIS OPTICA	0.333333	24.999981249995308
EPIDERMAL NEVUS SYNDROME	0.333333	24.999981249995308
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	24.999981249995308
NEONATAL MARFAN SYNDROME	0.333333	24.999981249995308
PSEUDO-VON WILLEBRAND DISEASE	0.333333	24.999981249995308
PULMONARY EDEMA OF MOUNTAINEERS	0.333333	24.999981249995308
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.333333	24.999981249995308
ISOTRETINOIN-LIKE SYNDROME	0.333333	24.999981249995308
IMMUNODEFICIENCY 46; IMD46	0.333333	24.999981249995308
H SYNDROME	0.3291337	24.685033671258413
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.30796524	23.09739877434969
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.30217395	22.66305191576298
AFRICAN IRON OVERLOAD	0.2952381	22.142863035715756
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.28507817	21.380868095217025
POEMS SYNDROME	0.27612156	20.70912217728054
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.27282412	20.461814115453528
WILSON DISEASE	0.26433840999999997	19.825385706346424
GLUTAMINE DEFICIENCY, CONGENITAL	0.2618436	19.638274909568725
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.26168912	19.626688906672225
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.25943396	19.457551864387966
118900 CIRRHOSIS, FAMILIAL	0.25869565	19.402178600544648
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25564275999999997	19.173211793302944
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.2555556	19.166674791668694
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25549451	19.16209304052326
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.25378788	19.03409575852394
ALSTROM SYNDROME; ALMS	0.25342466	19.006854251713563
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.25327869	18.995906498976623
DYSTONIA 6, TORSION	0.25	18.75000468750117
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.25	18.75000468750117
PARAGANGLIOMAS 1	0.25	18.75000468750117
TRICUSPID ATRESIA	0.25	18.75000468750117
HYPERPARATHYROIDISM 2	0.25	18.75000468750117
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.25	18.75000468750117
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.25	18.75000468750117
PARAGANGLIOMAS 3	0.25	18.75000468750117
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	18.75000468750117
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.25	18.75000468750117
CARNEY COMPLEX	0.25	18.75000468750117
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	18.75000468750117
RIGHT VENTRICULAR HYPOPLASIA, ISOLATED	0.25	18.75000468750117
GM2 GANGLIOSIDOSIS, AB VARIANT	0.25	18.75000468750117
PLEURAL MESOTHELIOMA	0.25	18.75000468750117
PARAGANGLIOMAS 4	0.25	18.75000468750117
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.25	18.75000468750117
USHER SYNDROME	0.25	18.75000468750117
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.25	18.75000468750117
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.25	18.75000468750117
LOWE OCULOCEREBRORENAL SYNDROME	0.25	18.75000468750117
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.25	18.75000468750117
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.24545450000000002	18.409092102273025
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.24545450000000002	18.409092102273025
BENIGN SCHWANNOMA	0.237037	17.77777944444486
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.2261903	16.964276741069185
BARE LYMPHOCYTE SYNDROME, TYPE II	0.225	16.875004218751055
HALOTHANE HEPATITIS	0.22413954	16.810469702617425
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.22324686	16.743518685879668
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.22113579000000003	16.5851883962971
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.21590910000000002	16.193186548296637
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.21364080000000002	16.023064005766003
MALARIA	0.213145	15.985878996469749
BRAIN-LUNG-THYROID SYNDROME	0.21220147	15.915114228778556
FRONTORHINY	0.21204820000000002	15.903618975904743
TRANSALDOLASE DEFICIENCY	0.21197434	15.89807947451987
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.21105972	15.829482957370738
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.21013990000000002	15.760496440124111
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.20986631	15.739977184994295
TETRASOMY 5P	0.20826446	15.619838404959602
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.20778598	15.5839523959881
POLYARTERITIS NODOSA	0.207156	15.53670388417597
CRYOGLOBULINEMIC VASCULITIS	0.20609541	15.457159614289903
CRI-DU-CHAT SYNDROME	0.20549451000000002	15.412092103023026
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.20537634000000002	15.403229350807338
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.20401606	15.30120832530208
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.20401606	15.30120832530208
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.20401606	15.30120832530208
FRONTONASAL DYSPLASIA 1; FND1	0.20393701	15.295279573819892
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.20393701	15.295279573819892
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.20327869	15.24590556147639
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.20240964	15.180726795181698
OCULOAURICULOFRONTONASAL SYNDROME	0.2	15.000003750000937
ADENYLOSUCCINATE LYASE DEFICIENCY	0.2	15.000003750000937
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.2	15.000003750000937
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.2	15.000003750000937
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.2	15.000003750000937
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.2	15.000003750000937
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.2	15.000003750000937
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	15.000003750000937
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	15.000003750000937
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	15.000003750000937
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	15.000003750000937
NON-FUNCTIONING PARAGANGLIOMA	0.2	15.000003750000937
MYH9-RELATED DISEASE	0.2	15.000003750000937
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	15.000003750000937
PRIMARY MYELOFIBROSIS	0.19556556	14.667420666855167
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.19321017	14.49076637269159
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.18492266000000002	13.869202967300742
NEUROFIBROMATOSIS TYPE 1	0.17938166	13.453627863406965
PERIPARTUM CARDIOMYOPATHY	0.17835612	13.376712344178085
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.17493146	13.119862779965693
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.17493146	13.119862779965693
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.17493146	13.119862779965693
DRACUNCULIASIS	0.17280197	12.960150990037747
KIKUCHI-FUJIMOTO DISEASE	0.17230976	12.923235230808809
CRYPTOSPORIDIOSIS	0.17068306	12.801232700308173
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17045488	12.784119196029797
MUCOLIPIDOSIS TYPE II	0.16903107	12.677333419333353
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	12.50002812500703
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	12.50002812500703
DERMATOLEUKODYSTROPHY	0.166667	12.50002812500703
CEREBROOCULONASAL SYNDROME	0.166667	12.50002812500703
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.166667	12.50002812500703
ADNP SYNDROME	0.15477720999999997	11.60829365207341
COFFIN-SIRIS SYNDROME 1; CSS1	0.15420459999999997	11.56534789133697
ROWLEY-ROSENBERG SYNDROME	0.14805272000000003	11.103956775989195
PHACE SYNDROME	0.14679400999999997	11.009553502388373
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14628165999999998	10.971127242781808
GANGLIONEUROMA	0.14628165999999998	10.971127242781808
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14628165999999998	10.971127242781808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14526663999999997	10.895000723750178
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.14526663999999997	10.895000723750178
DERMATOMYOSITIS	0.1444745	10.835590208897552
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.1432866	10.74649768662442
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.14285699999999998	10.714277678569417
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	10.714277678569417
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	10.714277678569417
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	10.714277678569417
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14285699999999998	10.714277678569417
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.14285699999999998	10.714277678569417
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	10.714277678569417
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14285699999999998	10.714277678569417
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	10.714277678569417
ALSTRÖM SYNDROME	0.14257998	10.693501173375292
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.1421131	10.65848516462129
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.13771265	10.32845133211283
CINCA SYNDROME	0.13723037999999999	10.292281073070267
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.13470874	10.103158025789504
HERMANSKY-PUDLAK SYNDROME	0.13443396	10.082549520637379
VASCULAR EHLERS-DANLOS SYNDROME	0.13333330000000002	10.0
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.1324787	9.935904983976245
NEUROLEPTIC MALIGNANT SYNDROME	0.13157104999999997	9.8678312169578
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.12955856999999998	9.716895179223792
16P13.2 MICRODELETION SYNDROME	0.12939384	9.704540426135107
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.12896809999999997	9.672609918152476
GIANT CELL ARTERITIS	0.12873134	9.654852913713228
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.12853554	9.640167910041978
PSEUDOXANTHOMA ELASTICUM	0.12842466	9.631851907962977
ZIMMERMANN-LABAND SYNDROME	0.12840353999999998	9.630267907566974
BERNARD-SOULIER SYNDROME	0.12827869	9.620904155226038
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.12740964	9.555725388931346
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.12736407	9.552307638076908
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.12736407	9.552307638076908
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.12568188	9.426143356535837
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.12551042999999998	9.413284603321149
SYSTEMIC SCLEROSIS	0.12551042999999998	9.413284603321149
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.125	9.375002343750586
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.125	9.375002343750586
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.125	9.375002343750586
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.125	9.375002343750586
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.125	9.375002343750586
3Q27.3 MICRODELETION SYNDROME	0.125	9.375002343750586
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.125	9.375002343750586
PRIMARY ERYTHROMELALGIA	0.125	9.375002343750586
COHEN SYNDROME	0.125	9.375002343750586
RHEUMATOID ARTHRITIS	0.1246143	9.346074836518708
PFAPA SYNDROME	0.12440814	9.330612832653209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.12322937999999999	9.242205810551452
TAKAYASU ARTERITIS	0.12310679999999999	9.233012308253077
PITT-HOPKINS-LIKE SYNDROME	0.12081973999999998	9.06148276537069
PORPHYRIA CUTANEA TARDA	0.11980664999999999	8.985500996375247
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.11889698	8.91727572931893
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.11889698	8.91727572931893
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.11885839999999999	8.914382228595557
PROPIONIC ACIDEMIA	0.11840574999999999	8.880433470108366
WARBURG MICRO SYNDROME 1	0.11745765	8.809325952331488
DOWN SYNDROME	0.11739921	8.804942951235738
ACUTE INTERMITTENT PORPHYRIA	0.11724596999999999	8.793449948362486
BETA-THALASSEMIA	0.11696006	8.772006693001673
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.1169231	8.769234692308672
ALG11-CDG	0.11688310000000002	8.766234691558674
22Q11.2 DELETION SYNDROME	0.11675375999999998	8.756534189133545
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.11657454000000002	8.743092685773172
OKAMOTO SYNDROME	0.11588470999999999	8.691355422838855
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.11512705999999999	8.634531658632913
COLCHICINE POISONING	0.11512705999999999	8.634531658632913
PETERS-PLUS SYNDROME; PTRPLS	0.11504800999999999	8.628602907150725
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.11489887999999998	8.617418154354537
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.1136364	8.522732130683032
HEPATOCELLULAR CARCINOMA	0.11359913000000002	8.51993687998422
PEHO SYNDROME; PEHO	0.11352063999999999	8.514050128512531
PEHO-LIKE SYNDROME; PEHOL	0.11352063999999999	8.514050128512531
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.11352063999999999	8.514050128512531
YUNIS-VARON SYNDROME	0.11220147000000001	8.415112353778088
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11212031	8.409025352256338
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.11131730000000001	8.348799587199897
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11111099999999999	8.333327083331769
SAY-BARBER-MILLER SYNDROME	0.11111099999999999	8.333327083331769
GLUTARIC ACIDEMIA I; GA1	0.11111099999999999	8.333327083331769
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.11111099999999999	8.333327083331769
CAREY-FINEMAN-ZITER SYNDROME	0.11111099999999999	8.333327083331769
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.11111099999999999	8.333327083331769
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.11111099999999999	8.333327083331769
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.11111099999999999	8.333327083331769
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.11111099999999999	8.333327083331769
FACIAL HYPERTRICHOSIS	0.11111099999999999	8.333327083331769
COG8-CDG	0.11111099999999999	8.333327083331769
CHROMOSOME 16P13.3 DELETION SYNDROME	0.11111099999999999	8.333327083331769
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.11111099999999999	8.333327083331769
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.11059684000000002	8.29476507369127
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.10986631000000001	8.239975309993827
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.10895317000000002	8.17148979287245
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.10876620000000001	8.15746703936676
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.10658910000000002	7.994184498546125
WILLIAMS SYNDROME	0.10613497000000001	7.960124740031185
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.10439314000000001	7.829487457371864
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.10373134	7.779852444963111
PSEUDOXANTHOMA ELASTICUM; PXE	0.10342466	7.75685143921286
FAMILIAL MELANOMA	0.10333330000000002	7.74999943749986
NOONAN SYNDROME	0.1031746	7.738096934524233
GRISCELLI SYNDROME	0.1031156	7.733671933417983
TRANSALDOLASE DEFICIENCY	0.10304805	7.72860568215142
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.10240964000000001	7.6807249201812295
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.10240964000000001	7.6807249201812295
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.10153763	7.615324153831038
MICROSPORIDIOSIS	0.1007746	7.558096889524222
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.10049574000000001	7.537182384295596
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.10034306000000001	7.525731381432846
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.1	7.500001875000469
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.1	7.500001875000469
LI-FRAUMENI SYNDROME	0.1	7.500001875000469
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.1	7.500001875000469
9Q31.1Q31.3 MICRODELETION SYNDROME	0.1	7.500001875000469
GRANGE SYNDROME; GRNG	0.1	7.500001875000469
RAVINE SYNDROME	0.1	7.500001875000469
ADAMS-OLIVER SYNDROME	0.0990502	7.428766857191714
CIRRHOSIS, FAMILIAL	0.09875376000000001	7.406533851633464
KAPOSI SARCOMA	0.0978213	7.336599334149834
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.09484611000000001	7.113460028365007
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.09469698	7.102275275568819
DISTAL TRISOMY 6P	0.09438341	7.07875751968938
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.09331874000000001	6.9989072497268126
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.09306904	6.980179745044936
VON HIPPEL-LINDAU DISEASE	0.09289293000000001	6.966971491742874
PEDIATRIC-ONSET GRAVES DISEASE	0.09212549	6.90941347735337
FRONTOMETAPHYSEAL DYSPLASIA	0.0909091	6.818184204546052
MONOSOMY 18Q	0.0909091	6.818184204546052
MACHADO-JOSEPH DISEASE TYPE 3	0.0909091	6.818184204546052
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0909091	6.818184204546052
MACHADO-JOSEPH DISEASE TYPE 2	0.0909091	6.818184204546052
PIERRE ROBIN SYNDROME	0.0909091	6.818184204546052
MACHADO-JOSEPH DISEASE TYPE 1	0.0909091	6.818184204546052
LYMPHOID INTERSTITIAL PNEUMONIA	0.0909091	6.818184204546052
SPINOCEREBELLAR ATAXIA TYPE 3	0.0909091	6.818184204546052
CYSTIC FIBROSIS	0.0909091	6.818184204546052
ULNAR-MAMMARY SYNDROME	0.0909091	6.818184204546052
GERMAN SYNDROME	0.0909091	6.818184204546052
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0909091	6.818184204546052
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0909091	6.818184204546052
BURKITT LYMPHOMA	0.09079097	6.809324452331113
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.08946827000000002	6.710121927530483
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.08897606000000001	6.673206168301542
MUCOLIPIDOSIS IV; ML4	0.0883459	6.62594415648604
COFFIN-SIRIS SYNDROME 3; CSS3	0.08816866999999999	6.612651903162975
COFFIN-SIRIS SYNDROME 2; CSS2	0.08816866999999999	6.612651903162975
COFFIN-SIRIS SYNDROME 4; CSS4	0.08816866999999999	6.612651903162975
DYSKERATOSIS CONGENITA	0.08767171000000001	6.575379893844974
CITRULLINEMIA TYPE II	0.08734936000000001	6.551203637800911
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08734936000000001	6.551203637800911
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.08734936000000001	6.551203637800911
CITRULLINEMIA TYPE I	0.08734936000000001	6.551203637800911
INFANTILE LIVER FAILURE SYNDROME 2	0.08734936000000001	6.551203637800911
ACUTE BILIRUBIN ENCEPHALOPATHY	0.08706464000000001	6.529849632462409
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.08706464000000001	6.529849632462409
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08680560000000001	6.510421627605408
TRICHOTHIODYSTROPHY	0.08680560000000001	6.510421627605408
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.08569737000000001	6.42730435682609
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.08465600000000001	6.3492015873003975
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.08412700000000001	6.309526577381644
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.08379399000000001	6.284550821137707
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	6.249999062499766
MYCETOMA	0.08333330000000001	6.249999062499766
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	6.249999062499766
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	6.249999062499766
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.08333330000000001	6.249999062499766
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.08333330000000001	6.249999062499766
HEPATIC VENO-OCCLUSIVE DISEASE	0.08333330000000001	6.249999062499766
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.08333330000000001	6.249999062499766
BULLOUS IMPETIGO	0.08333330000000001	6.249999062499766
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.08333330000000001	6.249999062499766
PATENT DUCTUS VENOSUS	0.08333330000000001	6.249999062499766
INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	6.249999062499766
PAPILLARY TUMOR OF THE PINEAL REGION	0.08305807000000001	6.229356807339202
PINEOCYTOMA	0.08305807000000001	6.229356807339202
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.07975935	5.9819527454881865
CLASSIC MYCOSIS FUNGOIDES	0.07928717	5.946539236634809
PHELAN-MCDERMID SYNDROME	0.07814426000000001	5.860820965205241
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.07785430000000002	5.83907395976849
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.07785059999999999	5.838796459699114
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.07692310000000001	5.769233942308485
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	5.769233942308485
N SYNDROME	0.07692310000000001	5.769233942308485
DERMOODONTODYSPLASIA	0.07692310000000001	5.769233942308485
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.07427204	5.570404392601098
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.07383824000000001	5.537869384467347
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.07383824000000001	5.537869384467347
COACH SYNDROME	0.07345448	5.509087377271844
ROMBO SYNDROME	0.0733333	5.499998874999719
VOGT-KOYANAGI-HARADA DISEASE	0.0733333	5.499998874999719
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0733333	5.499998874999719
MONILETHRIX	0.0733333	5.499998874999719
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.07142860000000001	5.357146339286585
3P25.3 MICRODELETION SYNDROME	0.07142860000000001	5.357146339286585
COG5-CDG	0.07142860000000001	5.357146339286585
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.07142860000000001	5.357146339286585
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07142860000000001	5.357146339286585
SPINOCEREBELLAR ATAXIA TYPE 2	0.07142860000000001	5.357146339286585
CEREBROFACIOARTICULAR SYNDROME	0.07088305	5.31623007905752
ADAMS-OLIVER SYNDROME 1; AOS1	0.06965436000000001	5.224078306019577
PRIMARY SCLEROSING CHOLANGITIS	0.06788902	5.091677772919442
MYELOPEROXIDASE DEFICIENCY	0.06768247999999999	5.076187269046816
NEONATAL LUPUS ERYTHEMATOSUS	0.06697816000000001	5.023363255840814
MERCURY POISONING	0.06673626	5.005220751305188
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.0667341	5.005058751264688
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0667341	5.005058751264688
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.06591831000000001	4.943874485968622
HOLOPROSENCEPHALY	0.06504354000000001	4.87826671956668
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.06498956	4.874218218554555
SICKLE CELL ANEMIA	0.0648604	4.864531216132804
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.0647549	4.856618714154679
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0627091	4.703183675795919
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.062334820000000006	4.6751126687781674
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0619813	4.6485986621496656
EVEN-PLUS SYNDROME	0.06194495	4.645872411468102
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.06150494	4.612871653217913
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.061080630000000004	4.581048395262099
STEINERT MYOTONIC DYSTROPHY	0.061050110000000005	4.578759394689849
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.060931940000000004	4.56989664247416
WITTEVEEN-KOLK SYNDROME	0.06053575	4.540182385045596
SALT-AND-PEPPER SYNDROME	0.059571660000000005	4.467875616968904
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.05949074	4.461806615451653
NIJMEGEN BREAKAGE SYNDROME	0.058834290000000004	4.412572853143213
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.05831312	4.373485093371273
WIEDEMANN-STEINER SYNDROME	0.0582886	4.371646092911523
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.05803833	4.352875838218959
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.05796524	4.347394086848522
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.05796524	4.347394086848522
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.05796524	4.347394086848522
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.05796524	4.347394086848522
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.05796524	4.347394086848522
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.05796524	4.347394086848522
PACHYDERMOPERIOSTOSIS	0.057919670000000006	4.343976335994084
LEGIONELLOSIS	0.057638579999999995	4.322894580723644
DISTAL TRISOMY 17Q	0.0573593	4.301948575487144
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.05720310000000001	4.290233572558393
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0571896	4.289221072305268
19P13.13 MICRODELETION SYNDROME	0.056928320000000004	4.269625067406267
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.05656861	4.242646810661702
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.05656861	4.242646810661702
KRABBE DISEASE	0.05654266	4.2407005601751395
219400 CYANOSIS AND HEPATIC DISEASE	0.056122500000000006	4.209188552297139
ADAMS-OLIVER SYNDROME 5; AOS5	0.056083030000000006	4.206228301557076
PYRUVATE CARBOXYLASE DEFICIENCY	0.055555600000000004	4.166671041667761
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.055555600000000004	4.166671041667761
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.055555600000000004	4.166671041667761
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.055555600000000004	4.166671041667761
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.055555600000000004	4.166671041667761
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.055555600000000004	4.166671041667761
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	4.166671041667761
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	4.166671041667761
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	4.166671041667761
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.055555600000000004	4.166671041667761
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	4.166671041667761
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.055555600000000004	4.166671041667761
SPINOCEREBELLAR ATAXIA TYPE 42	0.055555600000000004	4.166671041667761
ELLIS VAN CREVELD SYNDROME	0.055555600000000004	4.166671041667761
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.055555600000000004	4.166671041667761
RFT1-CDG	0.055555600000000004	4.166671041667761
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.055555600000000004	4.166671041667761
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	4.166671041667761
RHIZOMELIC SYNDROME, URBACH TYPE	0.055555600000000004	4.166671041667761
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.055555600000000004	4.166671041667761
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	4.166671041667761
COFFIN-SIRIS SYNDROME 6; CSS6	0.055555600000000004	4.166671041667761
NON-DISTAL MONOSOMY 20Q	0.055555600000000004	4.166671041667761
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	4.166671041667761
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.055383100000000005	4.153733538433384
BLAU SYNDROME	0.05482153000000001	4.111615777903944
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0544828	4.086211021552755
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05402227	4.051671262917815
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.05402227	4.051671262917815
19P13.3 MICRODUPLICATION SYNDROME	0.05371896	4.028923007230752
NEONATAL ACUTE RESPIRATORY DISTRESS DUE TO SP-B DEFICIENCY	0.05371896	4.028923007230752
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.05371896	4.028923007230752
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.05371896	4.028923007230752
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.05371896	4.028923007230752
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.053187040000000005	3.98902899725725
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.05311351	3.983514245878561
12Q14 MICRODELETION SYNDROME	0.05299534	3.974651493662873
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.05291226	3.968420492105123
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.05273216	3.954912988728247
KAPUR-TORIELLO SYNDROME	0.0526316	3.9473709868427465
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0526316	3.9473709868427465
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0526316	3.9473709868427465
JOUBERT SYNDROME 23; JBTS23	0.0526316	3.9473709868427465
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0526316	3.9473709868427465
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0526316	3.9473709868427465
CONGENITAL ENTEROVIRUS INFECTION	0.052418229999999996	3.9313682328420576
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.052359649999999994	3.926974731743682
PRIMARY BILIARY CHOLANGITIS	0.052359649999999994	3.926974731743682
SMITH-MAGENIS SYNDROME; SMS	0.05218745	3.914059728514932
AMYLOIDOSIS	0.052139099999999994	3.9104334776083687
MOWAT-WILSON SYNDROME	0.0520482	3.9036159759039935
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0516582	3.8743659685914924
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0516582	3.8743659685914924
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.05155601	3.8667017166754287
1P36 DELETION SYNDROME	0.05155601	3.8667017166754287
CEPHALIN LIPIDOSIS	0.05140688	3.855516963879241
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.05121871	3.8414042103510524
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.04979961	3.7349716837429208
SUSAC SYNDROME	0.04961327	3.720996180249045
ACROMICRIC DYSPLASIA	0.04943396	3.7075479268869818
CONGENITAL FIBRINOGEN DEFICIENCY	0.04918584	3.68893892223473
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04918584	3.68893892223473
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.049139539999999995	3.6854664213666046
TARP SYNDROME; TARPS	0.048972810000000006	3.6729616682404176
LICHTENSTEIN SYNDROME	0.048854640000000005	3.6640989160247295
COFFIN-SIRIS SYNDROME	0.04858811	3.6441091610272895
CAROLI DISEASE, ISOLATED	0.04854846	3.6411354102838525
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.04786414	3.589811397452849
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.04778021	3.583516645879161
ACROCEPHALOSYNDACTYLY	0.047619	3.5714258928564733
TUFTSIN DEFICIENCY	0.047619	3.5714258928564733
CEROID STORAGE DISEASE	0.047619	3.5714258928564733
DEXTROCARDIA	0.047619	3.5714258928564733
PAGOD SYNDROME	0.047619	3.5714258928564733
MEACHAM SYNDROME	0.047619	3.5714258928564733
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	3.5714258928564733
FEINGOLD SYNDROME	0.047619	3.5714258928564733
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.047494360000000006	3.562077890519473
PSEUDOTRISOMY 13 SYNDROME	0.04741531	3.5561491390372844
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.047266180000000005	3.5449643862410967
GAUCHER DISEASE	0.04674241	3.505681626420406
YUNIS-VARON SYNDROME	0.04668427	3.501321125330281
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.04636372	3.4772798693199674
C SYNDROME	0.04611411000000001	3.4585591146397787
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.04602807	3.452106113026528
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.04588794	3.44159636039909
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.04588794	3.44159636039909
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.04588794	3.44159636039909
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	3.4359608589902146
FONTAINE PROGEROID SYNDROME; FPS	0.04581234	3.435926358981589
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.04553477	3.4151086037771505
MESOMELIA-SYNOSTOSES SYNDROME	0.04549451	3.4120891030222755
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0454545	3.4090883522720885
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0454545	3.4090883522720885
JEJUNAL NEUROENDOCRINE TUMOR	0.0454545	3.4090883522720885
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	3.4090883522720885
CLASSIC MULTIMINICORE MYOPATHY	0.0454545	3.4090883522720885
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.0454545	3.4090883522720885
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0454545	3.4090883522720885
SANDIFER SYNDROME	0.0454545	3.4090883522720885
BRONCHOPULMONARY DYSPLASIA	0.0454545	3.4090883522720885
ADENOCARCINOMA OF OVARY	0.0454545	3.4090883522720885
GLYCEROL KINASE DEFICIENCY; GKD	0.0454545	3.4090883522720885
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0454545	3.4090883522720885
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.0454545	3.4090883522720885
DUBOWITZ SYNDROME	0.0454545	3.4090883522720885
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	3.4090883522720885
ILEAL NEUROENDOCRINE TUMOR	0.0454545	3.4090883522720885
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0454545	3.4090883522720885
SMITH-LEMLI-OPITZ SYNDROME	0.045381500000000005	3.403613350903338
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04472902	3.3546773386693345
SYSTEMIC MASTOCYTOSIS	0.043729180000000006	3.2796893199223307
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.043663999999999994	3.274800818700204
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	3.260873315218329
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	3.260873315218329
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.043478300000000004	3.260873315218329
JOUBERT SYNDROME 2	0.043478300000000004	3.260873315218329
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.043478300000000004	3.260873315218329
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	3.260873315218329
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.043478300000000004	3.260873315218329
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	3.260873315218329
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	3.260873315218329
JOUBERT SYNDROME 7	0.043478300000000004	3.260873315218329
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	3.260873315218329
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.043478300000000004	3.260873315218329
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.043478300000000004	3.260873315218329
JUVENILE XANTHOGRANULOMA	0.043478300000000004	3.260873315218329
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.043478300000000004	3.260873315218329
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	3.260873315218329
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.043478300000000004	3.260873315218329
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.043478300000000004	3.260873315218329
DE BARSY SYNDROME	0.043478300000000004	3.260873315218329
GLIOBLASTOMA	0.043478300000000004	3.260873315218329
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	3.260873315218329
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.043478300000000004	3.260873315218329
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.043478300000000004	3.260873315218329
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	3.260873315218329
CEDNIK SYNDROME	0.043478300000000004	3.260873315218329
PALLISTER-HALL SYNDROME	0.043478300000000004	3.260873315218329
HYPOPLASMINOGENEMIA	0.043478300000000004	3.260873315218329
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.043478300000000004	3.260873315218329
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.043478300000000004	3.260873315218329
TARP SYNDROME	0.043478300000000004	3.260873315218329
GASTROINTESTINAL STROMAL TUMOR	0.043171970000000004	3.23789855947464
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.042364070000000004	3.177306044326511
NIEMANN-PICK DISEASE TYPE B	0.04230972	3.1732297933074487
NAVAJO NEUROHEPATOPATHY	0.042123509999999996	3.1592640398160095
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.04180971000000001	3.1357290339322588
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.041684799999999994	3.126360781590195
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	3.061866765466691
NEONATAL ADRENOLEUKODYSTROPHY	0.04082488	3.061866765466691
MENTAL RETARDATION, BUENOS AIRES TYPE	0.04068396	3.0512977628244404
SOTOS SYNDROME	0.040619600000000006	3.0464707616176905
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.040619600000000006	3.0464707616176905
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.04045049	3.033787508446877
FANCONI ANEMIA	0.04031569	3.0236775059193763
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.04021591	3.016194004048501
BÖÖK SYNDROME	0.04	3.0000007500001873
MICROPHTHALMIA WITH LIMB ANOMALIES	0.04	3.0000007500001873
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	3.0000007500001873
ACRODERMATITIS ENTEROPATHICA	0.04	3.0000007500001873
ULERYTHEMA OPHRYOGENESIS	0.04	3.0000007500001873
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	3.0000007500001873
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04	3.0000007500001873
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04	3.0000007500001873
PILI TORTI	0.04	3.0000007500001873
TRIOPIA	0.04	3.0000007500001873
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	3.0000007500001873
SPONDYLO-OCULAR SYNDROME	0.04	3.0000007500001873
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	2.9976532494133115
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.03965131	2.9738489934622483
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.039502180000000005	2.96266424066606
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.039502180000000005	2.96266424066606
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.039502180000000005	2.96266424066606
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.039502180000000005	2.96266424066606
APOLIPOPROTEIN A-I DEFICIENCY	0.03940107	2.955080988770247
SITOSTEROLEMIA	0.03940107	2.955080988770247
RIDDLE SYNDROME	0.0391337	2.935028233757058
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.03883421	2.9125664781416196
FACIOSCAPULOHUMERAL DYSTROPHY	0.038827810000000004	2.9120864780216196
NEU-LAXOVA SYNDROME	0.038827810000000004	2.9120864780216196
NON-DISTAL TRISOMY 13Q	0.038709640000000003	2.9032237258059315
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.038709640000000003	2.9032237258059315
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.03849886	2.8874152218538054
ALEXANDER DISEASE	0.03849664	2.8872487218121803
COUMARIN RESISTANCE	0.03827068	2.8703017175754293
FLOOD FACTOR DEFICIENCY	0.03827068	2.8703017175754293
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03827068	2.8703017175754293
MACROCYTOSIS, FAMILIAL	0.03827068	2.8703017175754293
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03827068	2.8703017175754293
VIRAL HEMORRHAGIC FEVER	0.038145	2.8608757152189286
TRICHOHEPATOENTERIC SYNDROME 1	0.03810745	2.858059464514866
BUDD-CHIARI SYNDROME	0.03804686	2.8535152133788033
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.037907460000000004	2.843060210765053
REYNOLDS SYNDROME	0.03742699	2.8070249517562376
GAMMA-HEAVY CHAIN DISEASE	0.03734541	2.8009064502266123
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.03727031	2.7952739488184872
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.03727031	2.7952739488184872
BEHÇET DISEASE	0.03723038	2.7922791980697994
SCRUB TYPHUS	0.03723038	2.7922791980697994
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0370879	2.7815931953982984
LISSENCEPHALY 5; LIS5	0.0370879	2.7815931953982984
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0370482	2.778615694653924
ATRANSFERRINEMIA	0.037037	2.777775694443924
JEUNE SYNDROME	0.037037	2.777775694443924
POLAND SYNDROME	0.037037	2.777775694443924
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	2.777775694443924
FIBROSCLEROSIS, MULTIFOCAL	0.037037	2.777775694443924
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	2.777775694443924
RCAD (RENAL CYSTS AND DIABETES)	0.037037	2.777775694443924
RHYNS SYNDROME	0.037037	2.777775694443924
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	2.777775694443924
SLC39A8-CDG	0.037037	2.777775694443924
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	2.777775694443924
JACOBSEN SYNDROME	0.036611990000000004	2.7458999364749843
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.03596751	2.697563924390981
BLUE DIAPER SYNDROME	0.035714300000000004	2.6785731696432924
METHANE PRODUCTION	0.035714300000000004	2.6785731696432924
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	2.6785731696432924
PARANA HARD-SKIN SYNDROME	0.035714300000000004	2.6785731696432924
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	2.6785731696432924
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	2.6785731696432924
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	2.6785731696432924
TERATOMA, PINEAL	0.035714300000000004	2.6785731696432924
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	2.6785731696432924
GASTRIC SNEEZING	0.035714300000000004	2.6785731696432924
GALLBLADDER, AGENESIS OF	0.035714300000000004	2.6785731696432924
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	2.6785731696432924
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	2.6785731696432924
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	2.6785731696432924
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	2.6785731696432924
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	2.6785731696432924
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	2.6785731696432924
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.03537418	2.6530641632660403
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.035099399999999996	2.632455658113914
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.03507198	2.6303991575997894
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.03498134	2.623601155900289
NIPAH VIRUS DISEASE	0.03486631	2.6149739037434756
LYME DISEASE	0.03486631	2.6149739037434756
IMMUNOGLOBULIN A VASCULITIS	0.03486631	2.6149739037434756
RIFT VALLEY FEVER	0.03486631	2.6149739037434756
YELLOW FEVER	0.03486631	2.6149739037434756
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.03453561	2.590171397542849
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	2.5862106465526615
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	2.5862106465526615
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	2.5862106465526615
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	2.5862106465526615
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	2.5862106465526615
HEMOPOIETIC PROLIFERATION	0.0344828	2.5862106465526615
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	2.5862106465526615
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0344828	2.5862106465526615
ACETOPHENETIDIN SENSITIVITY	0.0344828	2.5862106465526615
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	2.5862106465526615
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	2.5862106465526615
CHANARIN-DORFMAN SYNDROME	0.0344828	2.5862106465526615
EOSINOPHILOPENIA	0.0344828	2.5862106465526615
PANNER DISEASE	0.0344828	2.5862106465526615
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0344828	2.5862106465526615
MYELOMA, MULTIPLE	0.0344828	2.5862106465526615
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.03432047	2.574035893508973
SCLEROSING CHOLANGITIS, NEONATAL	0.03431552	2.5736646434161607
TETRASOMY X	0.03406591	2.5549438887359717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.03365964	2.5244736311184077
OROFACIODIGITAL SYNDROME TYPE 14	0.03365964	2.5244736311184077
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.03365964	2.5244736311184077
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.03361407	2.52105588026397
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.03361407	2.52105588026397
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.03361407	2.52105588026397
COMMON VARIABLE IMMUNODEFICIENCY	0.03361407	2.52105588026397
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.03361407	2.52105588026397
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.03361407	2.52105588026397
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.03361407	2.52105588026397
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.03361407	2.52105588026397
LEPTOSPIROSIS	0.0335532	2.5164906291226568
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.0333333	2.4999981249995313
HYPERTRICHOSIS CUBITI	0.0333333	2.4999981249995313
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.0333333	2.4999981249995313
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0333333	2.4999981249995313
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0333333	2.4999981249995313
KID SYNDROME	0.0333333	2.4999981249995313
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.0333333	2.4999981249995313
LEUKONYCHIA TOTALIS	0.0333333	2.4999981249995313
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.0333333	2.4999981249995313
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.0333333	2.4999981249995313
DESBUQUOIS SYNDROME	0.0333333	2.4999981249995313
TRISOMY 13	0.0333333	2.4999981249995313
ALOPECIA ANTIBODY DEFICIENCY	0.0333333	2.4999981249995313
15Q13.3 MICRODELETION SYNDROME	0.03327231	2.495423873855968
INCONTINENTIA PIGMENTI	0.03326446	2.4948351237087807
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	2.4899766224941553
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	2.4899766224941553
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.03314314	2.4857361214340306
RAGWEED SENSITIVITY	0.03314314	2.4857361214340306
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.033120199999999995	2.4840156210039046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.03296454	2.4723411180852795
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.03277587	2.4581908645477157
NOCARDIOSIS	0.0327474	2.456055614013904
ISOLATED COMPLEX I DEFICIENCY	0.03268082	2.451062112765528
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03250841	2.4381313595328398
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.03230274	2.4227061056765264
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.03208942	2.4067071016767754
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.03195145	2.396359349089837
GLYCOGEN STORAGE DISEASE IV	0.03195145	2.396359349089837
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.03168912	2.3766845941711483
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.03130712	2.3480345870086468
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.03125	2.3437505859376464
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.03125	2.3437505859376464
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.03125	2.3437505859376464
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.03125	2.3437505859376464
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.03125	2.3437505859376464
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.03125	2.3437505859376464
IMMUNODEFICIENCY 62; IMD62	0.03125	2.3437505859376464
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.03125	2.3437505859376464
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.03125	2.3437505859376464
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.03125	2.3437505859376464
CONO-SPONDYLAR DYSPLASIA	0.03125	2.3437505859376464
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.03125	2.3437505859376464
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.03125	2.3437505859376464
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.03125	2.3437505859376464
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03125	2.3437505859376464
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.03125	2.3437505859376464
AICARDI SYNDROME	0.03125	2.3437505859376464
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.03125	2.3437505859376464
EVANS SYNDROME	0.03125	2.3437505859376464
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.03125	2.3437505859376464
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.03125	2.3437505859376464
AICARDI SYNDROME; AIC	0.03125	2.3437505859376464
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.03125	2.3437505859376464
KABUKI SYNDROME 1	0.03125	2.3437505859376464
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.03125	2.3437505859376464
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.03125	2.3437505859376464
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.03125	2.3437505859376464
WHIPPLE DISEASE	0.03109541	2.3321563330390833
AMERICAN TRYPANOSOMIASIS	0.03109541	2.3321563330390833
TYPHOID	0.03109541	2.3321563330390833
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03104178	2.3281340820335203
CYSTINOSIS	0.0310032	2.325240581310145
CHROMOSOME 1P36 DELETION SYNDROME	0.030953790000000002	2.321534830383708
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.03093547	2.3201608300402072
ALPHA-THALASSEMIA	0.03093547	2.3201608300402072
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.03064276	2.2982075745518937
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.03064276	2.2982075745518937
KAWASAKI DISEASE	0.030274509999999998	2.2705888176472038
SARCOIDOSIS	0.03026583	2.269937817484454
SSR4-CDG	0.0296815	2.226113056528264
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.029602450000000002	2.220184305046076
STUVE-WIEDEMANN SYNDROME	0.02954106	2.2155800538950134
ECHO VIRUS 11 SENSITIVITY	0.0294118	2.2058855514713875
IMMUNE SUPPRESSION	0.0294118	2.2058855514713875
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	2.2058855514713875
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.0294118	2.2058855514713875
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	2.2058855514713875
MONOMELIC AMYOTROPHY	0.0294118	2.2058855514713875
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	2.2058855514713875
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	2.2058855514713875
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	2.2058855514713875
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	2.2058855514713875
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	2.2058855514713875
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0294118	2.2058855514713875
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	2.2058855514713875
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	2.2058855514713875
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	2.2058855514713875
SHORT SYNDROME	0.0294118	2.2058855514713875
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	2.2058855514713875
MYASTHENIA GRAVIS; MG	0.0294118	2.2058855514713875
TRICHOHEPATOENTERIC SYNDROME 2	0.029103849999999997	2.1827892956973236
POLYCYTHEMIA VERA	0.02904453	2.1783402945850736
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.02904453	2.1783402945850736
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.02893954	2.1704660426165105
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.02873134	2.1548510387127595
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.028717319999999998	2.1537995384498845
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.028664759999999997	2.149857537464384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.028664759999999997	2.149857537464384
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	2.142855535713884
DISTAL MONOSOMY 7Q36	0.0285714	2.142855535713884
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0285714	2.142855535713884
ALG12-CDG	0.0285714	2.142855535713884
PROPIONIC ACIDEMIA	0.0285714	2.142855535713884
FETAL ALCOHOL SYNDROME	0.0285714	2.142855535713884
NORRIE DISEASE	0.0285714	2.142855535713884
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0285714	2.142855535713884
COFS SYNDROME	0.0285714	2.142855535713884
CONGENITAL LOBAR EMPHYSEMA	0.0285714	2.142855535713884
CHEILITIS GLANDULARIS	0.0285714	2.142855535713884
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	2.142855535713884
ACRODYSOSTOSIS	0.0285714	2.142855535713884
CONGENITAL DISORDER OF GLYCOSYLATION	0.0285714	2.142855535713884
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	2.142855535713884
COG7-CDG	0.0285714	2.142855535713884
22Q11.2 MICRODUPLICATION SYNDROME	0.0285714	2.142855535713884
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	2.142855535713884
ALG1-CDG	0.0285714	2.142855535713884
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	2.142855535713884
GALLOWAY-MOWAT SYNDROME	0.0285714	2.142855535713884
CHARGE SYNDROME	0.0285714	2.142855535713884
PENTASOMY X	0.0285714	2.142855535713884
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.028278690000000002	2.12090228022557
COMBINED SAPOSIN DEFICIENCY	0.02802951	2.1022137755534436
LYSINURIC PROTEIN INTOLERANCE	0.027895200000000002	2.092140523035131
MENKES DISEASE	0.027777800000000002	2.0833355208338804
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	2.0833355208338804
CYANIDE, INABILITY TO SMELL	0.027777800000000002	2.0833355208338804
DIMPLES, FACIAL	0.027777800000000002	2.0833355208338804
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	2.0833355208338804
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	2.0833355208338804
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	2.0833355208338804
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	2.0833355208338804
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	2.0833355208338804
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	2.0833355208338804
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	2.0833355208338804
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	2.0833355208338804
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	2.0833355208338804
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	2.0833355208338804
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	2.0833355208338804
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	2.0833355208338804
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	2.0833355208338804
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	2.0833355208338804
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	2.0833355208338804
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	2.0833355208338804
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	2.0833355208338804
OROFACIAL CLEFT 3	0.027777800000000002	2.0833355208338804
CLEFT CHIN	0.027777800000000002	2.0833355208338804
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	2.0833355208338804
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	2.0833355208338804
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	2.0833355208338804
NASAL BONES, ABSENCE OF	0.027777800000000002	2.0833355208338804
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	2.0833355208338804
DWARFISM, LEVI TYPE	0.027777800000000002	2.0833355208338804
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.027656729999999997	2.074255268563817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.02756584	2.0674385168596294
X-LINKED AGAMMAGLOBULINEMIA	0.02741823	2.0563677640919407
FAMILIAL HYPOALDOSTERONISM	0.02741157	2.055868263967066
GM1 GANGLIOSIDOSIS	0.02736407	2.0523057630764407
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.02729106	2.046830011707503
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.02729106	2.046830011707503
ENTERIC ANENDOCRINOSIS	0.027271860000000002	2.0453900113475028
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.02719281	2.039461259865315
LEISHMANIASIS	0.02691936	2.018952504738126
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.02691936	2.018952504738126
HYPOADRENOCORTICISM, FAMILIAL	0.02674336	2.0057525014381254
WILLIAMS-BEUREN SYNDROME; WBS	0.02668046	2.00103500025875
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.02666431	1.9998237499559375
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.02653449	1.9900872475218119
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02653449	1.9900872475218119
ADULT-ONSET STILL DISEASE	0.026503609999999997	1.9877712469428113
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.02645864	1.9843984960996237
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.026121560000000002	1.9591174897793724
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.02566544	1.9249084812271202
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.02566544	1.9249084812271202
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.02566544	1.9249084812271202
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.02566544	1.9249084812271202
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.02566544	1.9249084812271202
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.02566544	1.9249084812271202
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.02566544	1.9249084812271202
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.02566544	1.9249084812271202
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.02566544	1.9249084812271202
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.02561987	1.9214907303726825
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.02561987	1.9214907303726825
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02561987	1.9214907303726825
HARDIKAR SYNDROME	0.02561987	1.9214907303726825
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.025604500000000002	1.9203379800844949
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.025498220000000002	1.9123669780917445
PRADER-WILLI SYNDROME	0.02529782	1.8973369743342432
GITELMAN SYNDROME	0.02529266	1.8969499742374936
MILLER-DIEKER SYNDROME	0.02513694	1.8852709713177425
POTOCKI-LUPSKI SYNDROME	0.02513694	1.8852709713177425
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.025	1.8750004687501172
L-2-HYDROXYGLUTARIC ACIDURIA	0.025	1.8750004687501172
NEUROCUTANEOUS MELANOCYTOSIS	0.025	1.8750004687501172
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.025	1.8750004687501172
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.025	1.8750004687501172
HARTNUP DISEASE	0.025	1.8750004687501172
CRIGLER-NAJJAR SYNDROME	0.025	1.8750004687501172
IMMUNODEFICIENCY 37; IMD37	0.025	1.8750004687501172
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.02470126	1.8525949631487408
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.02455529	1.8416472104118027
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.02451904	1.8389284597321147
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.02419608	1.8147064536766133
AUTOSOMAL AGAMMAGLOBULINEMIA	0.024139539999999998	1.8104659526164877
MELIOIDOSIS	0.024139539999999998	1.8104659526164877
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.024139539999999998	1.8104659526164877
HEREDITARY COPROPORPHYRIA	0.02399207	1.7994056998514247
OROFACIODIGITAL SYNDROME TYPE 6	0.023953000000000002	1.7964754491188624
9Q21.13 MICRODELETION SYNDROME	0.023953000000000002	1.7964754491188624
AL AMYLOIDOSIS	0.023832859999999997	1.7874649468662365
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02378788	1.7840914460228614
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02373134	1.779850944962736
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.02368624	1.776468444117111
NAKAJO-NISHIMURA SYNDROME	0.02364067	1.7730506932626728
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.02364067	1.7730506932626728
FAMILIAL MEDITERRANEAN FEVER; FMF	0.02364067	1.7730506932626728
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.02359683	1.7697626924406729
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.02349986	1.7624899406224852
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.02349986	1.7624899406224852
ATAXIA-PANCYTOPENIA SYNDROME	0.02349986	1.7624899406224852
CONGENITAL HYPOTHYROIDISM	0.02342466	1.7568499392124848
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02342466	1.7568499392124848
SRD5A3-CDG	0.023351610000000002	1.751371187842797
GAUCHER DISEASE TYPE 3	0.02334118	1.7505889376472343
LYSOSOMAL ACID LIPASE DEFICIENCY	0.023340239999999998	1.7505184376296092
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0232558	1.744185436046359
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0232558	1.744185436046359
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0232558	1.744185436046359
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.0232558	1.744185436046359
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.0232558	1.744185436046359
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	1.744185436046359
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.0232558	1.744185436046359
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.0232558	1.744185436046359
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0232558	1.744185436046359
9Q33.3Q34.11 MICRODELETION SYNDROME	0.0232558	1.744185436046359
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0232558	1.744185436046359
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.0232558	1.744185436046359
ADAMS-OLIVER SYNDROME 6; AOS6	0.0232558	1.744185436046359
CEREBROTENDINOUS XANTHOMATOSIS	0.0232558	1.744185436046359
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0232558	1.744185436046359
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0232558	1.744185436046359
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0232558	1.744185436046359
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0232558	1.744185436046359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.02324686	1.743514935878734
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.02323344	1.742508435627109
SCLERODERMA	0.02309508	1.732131433032858
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.02307476	1.7306074326518581
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02307476	1.7306074326518581
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.02296214	1.7221609305402323
SMITH-MAGENIS SYNDROME	0.022919050000000003	1.718929179732295
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.022772269999999997	1.7079206769801691
MUCOPOLYSACCHARIDOSIS TYPE 7	0.022772269999999997	1.7079206769801691
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.7045479261369814
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	1.7045479261369814
THUMB DEFORMITY	0.0227273	1.7045479261369814
KAGAMI-OGATA SYNDROME	0.0227273	1.7045479261369814
SILVER-RUSSELL SYNDROME; SRS	0.0227273	1.7045479261369814
SILVER-RUSSELL SYNDROME	0.0227273	1.7045479261369814
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.7045479261369814
FATCO SYNDROME	0.0227273	1.7045479261369814
FETAL HYDANTOIN SYNDROME	0.0227273	1.7045479261369814
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.7045479261369814
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.7045479261369814
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.7045479261369814
ARTERIES, ANOMALIES OF	0.0227273	1.7045479261369814
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.7045479261369814
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	1.7045479261369814
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.7045479261369814
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.7045479261369814
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.7045479261369814
COWDEN SYNDROME 6; CWS6	0.0227273	1.7045479261369814
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.7045479261369814
COWDEN SYNDROME 5; CWS5	0.0227273	1.7045479261369814
SIRENOMELIA	0.0227273	1.7045479261369814
LARSEN SYNDROME	0.0227273	1.7045479261369814
COCAINE EMBRYOFETOPATHY	0.0227273	1.7045479261369814
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.7045479261369814
RHOMBENCEPHALOSYNAPSIS	0.0227273	1.7045479261369814
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.7045479261369814
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	1.7045479261369814
BETHLEM MYOPATHY 1	0.0227273	1.7045479261369814
WATSON SYNDROME	0.0227273	1.7045479261369814
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.7045479261369814
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.7045479261369814
GAUCHER DISEASE TYPE 1	0.022602869999999997	1.6952156738039181
NEPHROPATHIC INFANTILE CYSTINOSIS	0.021873160000000003	1.6404874101218527
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	1.6233739058434764
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.02164044	1.6230334057583513
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.02164044	1.6230334057583513
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.02164044	1.6230334057583513
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.02164044	1.6230334057583513
MELAS	0.02155543	1.6166576541644133
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.02148216	1.6111624027906006
ACROCALLOSAL SYNDROME; ACLS	0.021479720000000004	1.610979402744851
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.02133632	1.6002244000561
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.02133632	1.6002244000561
ADRENOCORTICAL CARCINOMA	0.02128176	1.5961323990330998
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.02127756	1.5958173989543498
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.02127756	1.5958173989543498
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0212766	1.5957453989363497
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0212766	1.5957453989363497
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0212766	1.5957453989363497
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0212766	1.5957453989363497
YAO SYNDROME	0.0212766	1.5957453989363497
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.0212766	1.5957453989363497
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0212766	1.5957453989363497
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.0212766	1.5957453989363497
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0212766	1.5957453989363497
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0212766	1.5957453989363497
IMMUNODEFICIENCY 61; IMD61	0.0212766	1.5957453989363497
MARSILI SYNDROME; MARSIS	0.0212766	1.5957453989363497
DOHLE BODIES AND LEUKEMIA	0.0212766	1.5957453989363497
IMMUNODEFICIENCY 9; IMD9	0.0212766	1.5957453989363497
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0212766	1.5957453989363497
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0212766	1.5957453989363497
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.0212766	1.5957453989363497
STÜVE-WIEDEMANN SYNDROME	0.0212766	1.5957453989363497
MAJEED SYNDROME	0.0212766	1.5957453989363497
KASABACH-MERRITT SYNDROME	0.02113579	1.5851846462961616
TUFTED ANGIOMA	0.02113579	1.5851846462961616
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.5771963942990983
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.5771963942990983
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.5771963942990983
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.5771963942990983
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.5771963942990983
MARSHALL-SMITH SYNDROME; MRSHSS	0.021002470000000002	1.5751856437964111
DUBOWITZ SYNDROME	0.020821400000000004	1.5616053904013478
BETA-THALASSEMIA MAJOR	0.02069145	1.5518591379647844
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.020678	1.5508503877125968
FANCONI ANEMIA	0.020678	1.5508503877125968
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.020453060000000002	1.533979883494971
LICHEN PLANOPILARIS	0.020408199999999998	1.5306153826538453
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.020408199999999998	1.5306153826538453
RELAPSING POLYCHONDRITIS	0.020408199999999998	1.5306153826538453
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	1.5306153826538453
CONGENITAL ISOLATED ACTH DEFICIENCY	0.020408199999999998	1.5306153826538453
OCCIPITAL HORN SYNDROME	0.020408199999999998	1.5306153826538453
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.020408199999999998	1.5306153826538453
MYASTHENIA GRAVIS	0.020408199999999998	1.5306153826538453
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.020408199999999998	1.5306153826538453
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.020384769999999997	1.5288581322145327
FG SYNDROME TYPE 1	0.020312660000000003	1.5234498808624704
WARBURG MICRO SYNDROME 3; WARBM3	0.020266740000000002	1.5200058800014702
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.020266740000000002	1.5200058800014702
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.020266740000000002	1.5200058800014702
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.020266740000000002	1.5200058800014702
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.020266740000000002	1.5200058800014702
MUCOPOLYSACCHARIDOSIS, TYPE II	0.02022117	1.516588129147032
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.02022117	1.516588129147032
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.02022117	1.516588129147032
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.02022117	1.516588129147032
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.020169259999999998	1.5126948781737193
VAN BOGAERT-HOZAY SYNDROME	0.02	1.5000003750000936
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	1.5000003750000936
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	1.5000003750000936
RENPENNING SYNDROME 1; RENS1	0.02	1.5000003750000936
TRICHODENTOOSSEOUS SYNDROME	0.02	1.5000003750000936
WERNER SYNDROME; WRN	0.02	1.5000003750000936
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	1.5000003750000936
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	1.5000003750000936
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	1.5000003750000936
DISSECTING CELLULITIS OF THE SCALP	0.02	1.5000003750000936
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	1.5000003750000936
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	1.5000003750000936
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	1.5000003750000936
HAIRY NOSE TIP	0.02	1.5000003750000936
INHERITED EPIDERMOLYSIS BULLOSA	0.02	1.5000003750000936
JUVENILE HYALINE FIBROMATOSIS	0.02	1.5000003750000936
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	1.5000003750000936
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	1.5000003750000936
COFFIN-LOWRY SYNDROME; CLS	0.02	1.5000003750000936
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	1.5000003750000936
CATATRICHY	0.02	1.5000003750000936
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.02	1.5000003750000936
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	1.5000003750000936
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	1.5000003750000936
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	1.5000003750000936
RINGED HAIR	0.02	1.5000003750000936
611426 TENTED EYEBROWS	0.02	1.5000003750000936
NEVUS COMEDONICUS SYNDROME	0.02	1.5000003750000936
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	1.5000003750000936
KNOBLOCH SYNDROME	0.02	1.5000003750000936
MIDPHALANGEAL HAIR	0.02	1.5000003750000936
DARIER DISEASE	0.02	1.5000003750000936
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	1.5000003750000936
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	1.5000003750000936
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	1.5000003750000936
INFANTILE MYOFIBROMATOSIS	0.02	1.5000003750000936
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	1.5000003750000936
STRIATE PALMOPLANTAR KERATODERMA	0.02	1.5000003750000936
HAIR WHORL	0.02	1.5000003750000936
ZTTK SYNDROME; ZTTKS	0.01980895	1.485671621417905
WHITE-SUTTON SYNDROME; WHSUS	0.01980895	1.485671621417905
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01960547	1.4704106176026541
MONOSOMY 22Q13.3	0.01950594	1.4629458657364662
BETA-THALASSEMIA INTERMEDIA	0.019324179999999996	1.4493138623284652
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.019324179999999996	1.4493138623284652
OROFACIODIGITAL SYNDROME I; OFD1	0.01926647	1.4449856112464028
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0192308	1.44231036057759
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0192308	1.44231036057759
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0192308	1.44231036057759
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0192308	1.44231036057759
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0192308	1.44231036057759
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0192308	1.44231036057759
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0192308	1.44231036057759
OPTIC ATROPHY 11; OPA11	0.0192308	1.44231036057759
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0192308	1.44231036057759
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.0192308	1.44231036057759
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0192308	1.44231036057759
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0192308	1.44231036057759
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.0192308	1.44231036057759
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0192308	1.44231036057759
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0192308	1.44231036057759
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.0192308	1.44231036057759
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0192308	1.44231036057759
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.0192308	1.44231036057759
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.0192308	1.44231036057759
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0191427	1.4357028589257146
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0191427	1.4357028589257146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0191427	1.4357028589257146
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0191427	1.4357028589257146
4Q21 MICRODELETION SYNDROME	0.018747310000000003	1.4060486015121505
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01842833	1.3821250955312736
SPONTANEOUS PERIODIC HYPOTHERMIA	0.018183170000000002	1.363738090934523
HUGHES-STOVIN SYNDROME	0.018130769999999997	1.3598080899520222
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.018129609999999997	1.359721089930272
CORNELIA DE LANGE SYNDROME 1	0.01808899	1.3566745891686471
AMISH INFANTILE EPILEPSY SYNDROME	0.0178571	1.3392828348207086
PEROXISOME BIOGENESIS DISORDER 6B	0.0178571	1.3392828348207086
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0178571	1.3392828348207086
SPASTIC PARAPLEGIA TYPE 7	0.0178571	1.3392828348207086
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0178571	1.3392828348207086
RABSON-MENDENHALL SYNDROME	0.0178571	1.3392828348207086
SECKEL SYNDROME 9; SCKL9	0.0178571	1.3392828348207086
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.0178571	1.3392828348207086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0178571	1.3392828348207086
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0178571	1.3392828348207086
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0178571	1.3392828348207086
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0178571	1.3392828348207086
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0178571	1.3392828348207086
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0178571	1.3392828348207086
BLOOM SYNDROME	0.0178571	1.3392828348207086
PAPILLON-LEFÈVRE SYNDROME	0.0178571	1.3392828348207086
ADRENOLEUKODYSTROPHY	0.0178571	1.3392828348207086
CHROMOSOME 17Q12 DELETION SYNDROME	0.0178571	1.3392828348207086
BARBER-SAY SYNDROME; BBRSAY	0.0178571	1.3392828348207086
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	1.3392828348207086
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0178571	1.3392828348207086
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.0178571	1.3392828348207086
FILIPPI SYNDROME; FLPIS	0.0178571	1.3392828348207086
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	1.3392828348207086
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.0178571	1.3392828348207086
49,XXXYY SYNDROME	0.0178571	1.3392828348207086
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0178571	1.3392828348207086
RAMON SYNDROME	0.0178571	1.3392828348207086
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	1.3392828348207086
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0178571	1.3392828348207086
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0178571	1.3392828348207086
LEIGH SYNDROME; LS	0.0178571	1.3392828348207086
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	1.3392828348207086
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	1.3392828348207086
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.0178571	1.3392828348207086
TENORIO SYNDROME; TNORS	0.0178571	1.3392828348207086
CHROMOSOME 18Q DELETION SYNDROME	0.0178571	1.3392828348207086
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	1.3392828348207086
JUVENILE HUNTINGTON DISEASE	0.0178571	1.3392828348207086
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0178571	1.3392828348207086
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	1.3392828348207086
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	1.3392828348207086
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.0178571	1.3392828348207086
49,XYYYY SYNDROME	0.0178571	1.3392828348207086
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.0178571	1.3392828348207086
MEGALENCEPHALY WITH DYSMYELINATION	0.0178571	1.3392828348207086
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	1.3392828348207086
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0178571	1.3392828348207086
ADDUCTED THUMBS SYNDROME	0.0178571	1.3392828348207086
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	1.3392828348207086
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0178571	1.3392828348207086
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0178571	1.3392828348207086
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0178571	1.3392828348207086
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0178571	1.3392828348207086
METACHROMATIC LEUKODYSTROPHY	0.0178571	1.3392828348207086
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	1.3392828348207086
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	1.3392828348207086
LISSENCEPHALY 1; LIS1	0.0178571	1.3392828348207086
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.01769842	1.3273818318454578
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01769842	1.3273818318454578
15Q OVERGROWTH SYNDROME	0.01769598	1.3271988317997079
MICROPHTHALMIA, LENZ TYPE	0.017542710000000003	1.3157035789258948
FRONTONASAL DYSPLASIA	0.017542710000000003	1.3157035789258948
HOLZGREVE SYNDROME	0.017542710000000003	1.3157035789258948
FEMORAL-FACIAL SYNDROME	0.017542710000000003	1.3157035789258948
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.017542710000000003	1.3157035789258948
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.017399309999999998	1.3049485762371438
184705 STEINFELD SYNDROME	0.017399309999999998	1.3049485762371438
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	1.3049485762371438
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017399309999999998	1.3049485762371438
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.017399309999999998	1.3049485762371438
FRANK-TER HAAR SYNDROME; FTHS	0.017399309999999998	1.3049485762371438
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	1.3049485762371438
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	1.3049485762371438
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.017399309999999998	1.3049485762371438
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.017399309999999998	1.3049485762371438
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	1.3049485762371438
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.017399309999999998	1.3049485762371438
CAMPOMELIC DYSPLASIA	0.017399309999999998	1.3049485762371438
GAUCHER DISEASE, TYPE I	0.01733188	1.2998913249728312
FABRY DISEASE	0.01730703	1.2980275745068937
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.01728114	1.296085824021456
9Q SUBTELOMERIC DELETION SYNDROME	0.01728114	1.296085824021456
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.2931053232763308
MYOPATHY, CONGENITAL	0.0172414	1.2931053232763308
MOTION SICKNESS	0.0172414	1.2931053232763308
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.2931053232763308
DIASTEMATOMYELIA	0.0172414	1.2931053232763308
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.2931053232763308
MOSAIC TRISOMY 15	0.0172414	1.2931053232763308
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.2931053232763308
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.2931053232763308
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.2931053232763308
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.2931053232763308
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.2931053232763308
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.2931053232763308
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.2931053232763308
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.2931053232763308
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.2931053232763308
ERYTHERMALGIA, PRIMARY	0.0172414	1.2931053232763308
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.2931053232763308
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.2931053232763308
CARDIAC ARRHYTHMIA	0.0172414	1.2931053232763308
ALCOHOL DEPENDENCE	0.0172414	1.2931053232763308
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.2931053232763308
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.2931053232763308
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.2931053232763308
PALMOMENTAL REFLEX	0.0172414	1.2931053232763308
CERVICAL RIB	0.0172414	1.2931053232763308
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.2931053232763308
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.2931053232763308
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.2931053232763308
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.2931053232763308
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.2931053232763308
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.2931053232763308
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.2931053232763308
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.2931053232763308
JUMPING FRENCHMAN OF MAINE	0.0172414	1.2931053232763308
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.2931053232763308
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.2931053232763308
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.2931053232763308
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.2931053232763308
THUMBS, CONGENITAL CLASPED	0.0172414	1.2931053232763308
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.2931053232763308
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.2931053232763308
269800 SENILE PLAQUE FORMATION	0.0172414	1.2931053232763308
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01721994	1.2914958228739555
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.01721994	1.2914958228739555
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.01721994	1.2914958228739555
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.01721994	1.2914958228739555
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.01721994	1.2914958228739555
CHOLESTERYL ESTER STORAGE DISEASE	0.01719469	1.289602072400518
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.01719469	1.289602072400518
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.01696011	1.272008568002142
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.01687468	1.2656013164003288
RHABDOID TUMOR	0.01656966	1.2427248106812026
LETTERER-SIWE DISEASE	0.01644399	1.2332995583248894
CRYPTOCOCCOSIS	0.01644305	1.2332290583072645
AA AMYLOIDOSIS	0.01592086	1.1940647985161994
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.015841809999999998	1.1881360470340114
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.01563148	1.172361293090323
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01550907	1.1631805407951352
BABESIOSIS	0.01550907	1.1631805407951352
FIBULAR HEMIMELIA	0.015183489999999997	1.1387620346905083
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.01512229	1.1341720335430083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.01508508	1.1313812828453207
FLOATING-HARBOR SYNDROME	0.01492847	1.1196355299088823
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.01492847	1.1196355299088823
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.01483062	1.1122967780741944
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0148103	1.1107727776931944
MICROTRIPLICATION 11Q24.1	0.0148103	1.1107727776931944
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0148103	1.1107727776931944
ALAZAMI-YUAN SYNDROME	0.0148103	1.1107727776931944
CORNELIA DE LANGE SYNDROME 3	0.0148103	1.1107727776931944
CORNELIA DE LANGE SYNDROME	0.0148103	1.1107727776931944
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0148103	1.1107727776931944
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0148103	1.1107727776931944
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.0148103	1.1107727776931944
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0148103	1.1107727776931944
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0148103	1.1107727776931944
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0148103	1.1107727776931944
MONOSOMY 9P	0.014807860000000003	1.1105897776474445
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014611109999999998	1.0958335239583807
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.014484379999999998	1.0863287715821928
PRIMARY LIPODYSTROPHY	0.014484379999999998	1.0863287715821928
HEART AND BRAIN MALFORMATION SYNDROME	0.014457840000000001	1.0843382710845677
CREST SYNDROME	0.01439943	1.0799575199893798
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.01439943	1.0799575199893798
COG4-CDG	0.01438398	1.0787987696996924
MIXED CONNECTIVE TISSUE DISEASE	0.01435987	1.0769905192476297
SEA-BLUE HISTIOCYTE DISEASE	0.01433841	1.0753810188452546
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.014314439999999998	1.0735832683958169
SCHINZEL-GIEDION SYNDROME	0.014314439999999998	1.0735832683958169
MEND SYNDROME	0.014314439999999998	1.0735832683958169
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.014268869999999998	1.0701655175413791
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.013907219999999998	1.04304176076044
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0137248	1.0293602573400644
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.013645750000000002	1.0234315058578767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.013469359999999998	1.010202252550563
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.01345002	1.008751752187938
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01345002	1.008751752187938
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.01345002	1.008751752187938
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.01345002	1.008751752187938
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.01345002	1.008751752187938
2Q23.1 MICRODUPLICATION SYNDROME	0.01345002	1.008751752187938
GLYCINE ENCEPHALOPATHY; GCE	0.01337097	1.0028230007057501
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01337097	1.0028230007057501
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01337097	1.0028230007057501
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.01337097	1.0028230007057501
GRANULOMATOSIS WITH POLYANGIITIS	0.01329097	0.9968229992057497
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.01329097	0.9968229992057497
PITUITARY APOPLEXY	0.01329097	0.9968229992057497
PORPHYRIA	0.01329097	0.9968229992057497
BOHRING-OPITZ SYNDROME	0.01328049	0.9960369990092498
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01323492	0.992619248154812
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.0131653	0.9873977468494366
ENCEPHALITIS LETHARGICA	0.0131653	0.9873977468494366
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.0131653	0.9873977468494366
STEVENS-JOHNSON SYNDROME	0.013145	0.9858752464688116
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.013145	0.9858752464688116
DENGUE FEVER	0.013145	0.9858752464688116
LASSA FEVER	0.013145	0.9858752464688116
MARBURG HEMORRHAGIC FEVER	0.013145	0.9858752464688116
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.013044690000000001	0.9783519945879986
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01285862	0.9643967410991852
APERT SYNDROME	0.012856180000000002	0.9642137410534354
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.012712649999999999	0.9534489883622469
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.012712649999999999	0.9534489883622469
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.01271171	0.9533784883446219
GALACTOSEMIA	0.01271171	0.9533784883446219
CITRULLINEMIA, CLASSIC	0.01271171	0.9533784883446219
LYSOSOMAL ACID LIPASE DEFICIENCY	0.01228052	0.9210392302598075
FAMILIAL MEDITERRANEAN FEVER	0.012230379999999999	0.9172787293196822
NODULAR NON-SUPPURATIVE PANNICULITIS	0.012230379999999999	0.9172787293196822
WOLMAN DISEASE	0.012230379999999999	0.9172787293196822
GRISCELLI SYNDROME TYPE 2	0.012230379999999999	0.9172787293196822
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.012201469999999999	0.9151104787776195
ACQUIRED GENERALIZED LIPODYSTROPHY	0.012120309999999999	0.9090234772558692
TURNER SYNDROME	0.012120309999999999	0.9090234772558692
MONOSOMY X	0.012120309999999999	0.9090234772558692
MOSAIC MONOSOMY X	0.012120309999999999	0.9090234772558692
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.012120309999999999	0.9090234772558692
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.01211838	0.9088787272196817
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.01211838	0.9088787272196817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.01211838	0.9088787272196817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.01211838	0.9088787272196817
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.01211838	0.9088787272196817
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.01211838	0.9088787272196817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.01211838	0.9088787272196817
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.01205234	0.9039257259814314
MECKEL SYNDROME	0.012048200000000002	0.9036152259038066
DIABETIC EMBRYOPATHY	0.012048200000000002	0.9036152259038066
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012048200000000002	0.9036152259038066
FRONTAL ENCEPHALOCELE	0.012048200000000002	0.9036152259038066
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.012048200000000002	0.9036152259038066
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.012048200000000002	0.9036152259038066
SCHIZENCEPHALY	0.012048200000000002	0.9036152259038066
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.012048200000000002	0.9036152259038066
DISTAL TRISOMY 14Q	0.012048200000000002	0.9036152259038066
LOWRY-WOOD SYNDROME	0.012048200000000002	0.9036152259038066
COFFIN-LOWRY SYNDROME	0.012048200000000002	0.9036152259038066
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.012048200000000002	0.9036152259038066
TEMTAMY SYNDROME	0.012048200000000002	0.9036152259038066
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.012048200000000002	0.9036152259038066
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.012048200000000002	0.9036152259038066
MICRO SYNDROME	0.012048200000000002	0.9036152259038066
LINEAR VERRUCOUS NEVUS SYNDROME	0.012048200000000002	0.9036152259038066
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.012048200000000002	0.9036152259038066
LINEAR NEVUS SEBACEUS SYNDROME	0.012048200000000002	0.9036152259038066
ISOLATED DANDY-WALKER MALFORMATION	0.012048200000000002	0.9036152259038066
KOOLEN-DE VRIES SYNDROME	0.012048200000000002	0.9036152259038066
OCULO-PALATO-CEREBRAL SYNDROME	0.012048200000000002	0.9036152259038066
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.012048200000000002	0.9036152259038066
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.012048200000000002	0.9036152259038066
PETERS PLUS SYNDROME	0.012048200000000002	0.9036152259038066
DONNAI-BARROW SYNDROME	0.012048200000000002	0.9036152259038066
HARTSFIELD SYNDROME	0.012048200000000002	0.9036152259038066
ACROCALLOSAL SYNDROME	0.012048200000000002	0.9036152259038066
CRANE-HEISE SYNDROME	0.012048200000000002	0.9036152259038066
SHORT RIB-POLYDACTYLY SYNDROME	0.012048200000000002	0.9036152259038066
PYRUVATE DEHYDROGENASE DEFICIENCY	0.012048200000000002	0.9036152259038066
PITT-HOPKINS SYNDROME	0.012048200000000002	0.9036152259038066
OCULOCEREBROCUTANEOUS SYNDROME	0.012048200000000002	0.9036152259038066
PRIMARY CUTIS VERTICIS GYRATA	0.012048200000000002	0.9036152259038066
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.012048200000000002	0.9036152259038066
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.012048200000000002	0.9036152259038066
PAI SYNDROME	0.012048200000000002	0.9036152259038066
DISTAL MONOSOMY 1Q	0.012048200000000002	0.9036152259038066
8Q21.11 MICRODELETION SYNDROME	0.012048200000000002	0.9036152259038066
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.012048200000000002	0.9036152259038066
CHRISTIANSON SYNDROME	0.012048200000000002	0.9036152259038066
TRIPLOIDY	0.012048200000000002	0.9036152259038066
TRISOMY 18	0.012048200000000002	0.9036152259038066
JOUBERT SYNDROME	0.012048200000000002	0.9036152259038066
DISTAL MONOSOMY 13Q	0.012048200000000002	0.9036152259038066
LAURIN-SANDROW SYNDROME	0.012048200000000002	0.9036152259038066
3-HYDROXYISOBUTYRIC ACIDURIA	0.012048200000000002	0.9036152259038066
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012048200000000002	0.9036152259038066
JUNG SYNDROME	0.012048200000000002	0.9036152259038066
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.012048200000000002	0.9036152259038066
ANTISYNTHETASE SYNDROME	0.0119958	0.8996852249213061
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.01197434	0.898075724518931
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.011904799999999998	0.8928602232150556
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.8928602232150556
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.8928602232150556
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.011904799999999998	0.8928602232150556
TRANSIENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.8928602232150556
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.011904799999999998	0.8928602232150556
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.011904799999999998	0.8928602232150556
CONGENITAL HYDROCEPHALUS	0.011904799999999998	0.8928602232150556
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011904799999999998	0.8928602232150556
UNILATERAL POLYMICROGYRIA	0.011904799999999998	0.8928602232150556
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.011904799999999998	0.8928602232150556
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.8928602232150556
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011904799999999998	0.8928602232150556
LOWRY-MACLEAN SYNDROME	0.011904799999999998	0.8928602232150556
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.8928602232150556
7P22.1 MICRODUPLICATION SYNDROME	0.011904799999999998	0.8928602232150556
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011904799999999998	0.8928602232150556
PERMANENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.8928602232150556
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.011904799999999998	0.8928602232150556
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.8928602232150556
WOLCOTT-RALLISON SYNDROME	0.011904799999999998	0.8928602232150556
MILLER-DIEKER SYNDROME (MDS)	0.011904799999999998	0.8928602232150556
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.011904799999999998	0.8928602232150556
PLACENTAL INSUFFICIENCY	0.011904799999999998	0.8928602232150556
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011904799999999998	0.8928602232150556
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.011904799999999998	0.8928602232150556
HELSMOORTEL-VAN DER AA SYNDROME	0.011904799999999998	0.8928602232150556
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.8928602232150556
TONNE-KALSCHEUER SYNDROME; TOKAS	0.011904799999999998	0.8928602232150556
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.011904799999999998	0.8928602232150556
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0118436	0.8882702220675553
COFFIN-SIRIS SYNDROME 5	0.0118436	0.8882702220675553
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0118436	0.8882702220675553
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0118436	0.8882702220675553
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0118436	0.8882702220675553
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0118436	0.8882702220675553
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0118436	0.8882702220675553
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0118436	0.8882702220675553
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0118436	0.8882702220675553
8Q24.3 MICRODELETION SYNDROME	0.0118436	0.8882702220675553
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0118436	0.8882702220675553
PITT-HOPKINS SYNDROME	0.0118436	0.8882702220675553
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0118436	0.8882702220675553
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0118436	0.8882702220675553
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0118436	0.8882702220675553
AYMÉ-GRIPP SYNDROME	0.0118436	0.8882702220675553
GAUCHER DISEASE TYPE 2	0.01179803	0.8848524712131177
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.01177773	0.8833299708324925
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01172299	0.8792244698061175
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.011689119999999999	0.8766842191710547
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.011689119999999999	0.8766842191710547
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.011689119999999999	0.8766842191710547
HALLERMANN-STREIFF SYNDROME; HSS	0.011689119999999999	0.8766842191710547
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.011689119999999999	0.8766842191710547
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.011689119999999999	0.8766842191710547
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.011689119999999999	0.8766842191710547
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.011689119999999999	0.8766842191710547
AORTA COARCTATION	0.011689119999999999	0.8766842191710547
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.011689119999999999	0.8766842191710547
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.011689119999999999	0.8766842191710547
HISTIOCYTOID CARDIOMYOPATHY	0.011684410000000001	0.8763309690827423
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.011543149999999999	0.8657364664341164
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.011543149999999999	0.8657364664341164
BETA-KETOTHIOLASE DEFICIENCY	0.011172060000000001	0.8379047094761773
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.011059719999999999	0.8294792073698017
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.011059719999999999	0.8294792073698017
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.011059719999999999	0.8294792073698017
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.011059719999999999	0.8294792073698017
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.011059719999999999	0.8294792073698017
HEMOCHROMATOSIS, TYPE 1	0.011059719999999999	0.8294792073698017
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.011059719999999999	0.8294792073698017
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.011059719999999999	0.8294792073698017
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.011059719999999999	0.8294792073698017
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.011059719999999999	0.8294792073698017
TYROSINEMIA, TYPE I; TYRSN1	0.011059719999999999	0.8294792073698017
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.011059719999999999	0.8294792073698017
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.011059719999999999	0.8294792073698017
GLYCOGEN STORAGE DISEASE IXC	0.011059719999999999	0.8294792073698017
HEMOCHROMATOSIS, TYPE 2B	0.011059719999999999	0.8294792073698017
HEMOCHROMATOSIS, TYPE 2A	0.011059719999999999	0.8294792073698017
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.011059719999999999	0.8294792073698017
SYNDROMIC DIARRHEA	0.011059719999999999	0.8294792073698017
IMMUNODEFICIENCY 47	0.011059719999999999	0.8294792073698017
ISOLATED BILIARY ATRESIA	0.011059719999999999	0.8294792073698017
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.01102609	0.8269569567392391
RELAPSING FEVER	0.01102609	0.8269569567392391
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.010870850000000001	0.8153139538284886
MCDONOUGH SYNDROME	0.010870850000000001	0.8153139538284886
WAARDENBURG SYNDROME TYPE 1	0.010870850000000001	0.8153139538284886
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.010870850000000001	0.8153139538284886
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.01071941	0.8039559509889876
ALPORT SYNDROME	0.01071941	0.8039559509889876
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.010674099999999999	0.800557700139425
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.010674099999999999	0.800557700139425
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.010674099999999999	0.800557700139425
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.010640360000000001	0.7980271995067999
FAMILIAL THROMBOCYTOSIS	0.010628529999999999	0.7971399492849872
HURLER-SCHEIE SYNDROME	0.010628529999999999	0.7971399492849872
KAGAMI-OGATA SYNDROME	0.010628529999999999	0.7971399492849872
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.010628529999999999	0.7971399492849872
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01043469	0.7826019456504864
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.01021358	0.7660186915046728
PLAGUE	0.010111470000000001	0.7583604395901099
XP21 MICRODELETION SYNDROME	0.010071980000000001	0.7553986888496723
RABIES	0.00986631	0.7399734349933587
RHEUMATIC FEVER	0.00986631	0.7399734349933587
LUJO HEMORRHAGIC FEVER	0.00986631	0.7399734349933587
FAMILIAL COLD URTICARIA	0.00986631	0.7399734349933587
ERDHEIM-CHESTER DISEASE	0.00986631	0.7399734349933587
PAROXYSMAL COLD HEMOGLOBINURIA	0.00986631	0.7399734349933587
NEPHROGENIC DIABETES INSIPIDUS	0.00986631	0.7399734349933587
MALT LYMPHOMA	0.00986631	0.7399734349933587
MICROSCOPIC POLYANGIITIS	0.00986631	0.7399734349933587
CENTRAL DIABETES INSIPIDUS	0.00986631	0.7399734349933587
RECURRENT ACUTE PANCREATITIS	0.00986631	0.7399734349933587
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00986631	0.7399734349933587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00970874	0.7281556820389206
EARLY MYOCLONIC ENCEPHALOPATHY	0.00970874	0.7281556820389206
MYOCLONIC-ASTASTIC EPILEPSY	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.00970874	0.7281556820389206
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00970874	0.7281556820389206
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.00970874	0.7281556820389206
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00970874	0.7281556820389206
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00970874	0.7281556820389206
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.00970874	0.7281556820389206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.00970874	0.7281556820389206
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00970874	0.7281556820389206
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00970874	0.7281556820389206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.00970874	0.7281556820389206
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00970874	0.7281556820389206
RAYNAUD-CLAES SYNDROME; MRXSRC	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.00970874	0.7281556820389206
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00970874	0.7281556820389206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00970874	0.7281556820389206
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.00970874	0.7281556820389206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00970874	0.7281556820389206
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00965882	0.7244116811029202
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00955963	0.7169724292431072
CARNEY TRIAD	0.00955963	0.7169724292431072
PAROXYSMAL HEMICRANIA	0.00955963	0.7169724292431072
ROTHMUND-THOMSON SYNDROME	0.00955963	0.7169724292431072
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00943396	0.7075471768867941
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.00943396	0.7075471768867941
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00943396	0.7075471768867941
2P15P16.1 MICRODELETION SYNDROME	0.00943396	0.7075471768867941
OGDEN SYNDROME; OGDNS	0.00943396	0.7075471768867941
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00943396	0.7075471768867941
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00943396	0.7075471768867941
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00943396	0.7075471768867941
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00943396	0.7075471768867941
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00943396	0.7075471768867941
COFFIN-SIRIS SYNDROME 8; CSS8	0.00943396	0.7075471768867941
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00943396	0.7075471768867941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00943396	0.7075471768867941
LENNOX-GASTAUT SYNDROME	0.00943396	0.7075471768867941
MEIER-GORLIN SYNDROME 1; MGORS1	0.00943396	0.7075471768867941
OLIVER-MCFARLANE SYNDROME	0.00943396	0.7075471768867941
HYPEREKPLEXIA 4; HKPX4	0.00943396	0.7075471768867941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00943396	0.7075471768867941
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.00943396	0.7075471768867941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00943396	0.7075471768867941
TRICHOMEGALY; TCMGLY	0.00943396	0.7075471768867941
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.00943396	0.7075471768867941
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00943396	0.7075471768867941
2P21 MICRODELETION SYNDROME	0.00943396	0.7075471768867941
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00943396	0.7075471768867941
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00943396	0.7075471768867941
IMMUNODEFICIENCY 44	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00943396	0.7075471768867941
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.7075471768867941
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00943396	0.7075471768867941
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00943396	0.7075471768867941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00943396	0.7075471768867941
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00943396	0.7075471768867941
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00943396	0.7075471768867941
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00943396	0.7075471768867941
MAN1B1-CDG	0.00943396	0.7075471768867941
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.7075471768867941
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00943396	0.7075471768867941
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00943396	0.7075471768867941
HYPOTONIA-CYSTINURIA SYNDROME	0.00943396	0.7075471768867941
KABUKI SYNDROME	0.00943396	0.7075471768867941
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00943396	0.7075471768867941
TEMPLE-BARAITSER SYNDROME	0.00943396	0.7075471768867941
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00943396	0.7075471768867941
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.00943396	0.7075471768867941
FADD-RELATED IMMUNODEFICIENCY	0.00943396	0.7075471768867941
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00943396	0.7075471768867941
ETHYLMALONIC ENCEPHALOPATHY	0.00943396	0.7075471768867941
COHEN SYNDROME	0.00943396	0.7075471768867941
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00943396	0.7075471768867941
ACROMICRIC DYSPLASIA	0.00943396	0.7075471768867941
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00943396	0.7075471768867941
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00943396	0.7075471768867941
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.00943396	0.7075471768867941
ACROCARDIOFACIAL SYNDROME	0.00943396	0.7075471768867941
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00943396	0.7075471768867941
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.00943396	0.7075471768867941
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00943396	0.7075471768867941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.00943396	0.7075471768867941
KENNERKNECHT SYNDROME	0.00943396	0.7075471768867941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00943396	0.7075471768867941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00943396	0.7075471768867941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00943396	0.7075471768867941
HYDROXYKYNURENINURIA	0.00943396	0.7075471768867941
FLOATING-HARBOR SYNDROME	0.00943396	0.7075471768867941
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00943396	0.7075471768867941
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00943396	0.7075471768867941
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00943396	0.7075471768867941
CHOPS SYNDROME; CHOPS	0.00943396	0.7075471768867941
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00943396	0.7075471768867941
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00943396	0.7075471768867941
7Q11.23 MICRODUPLICATION SYNDROME	0.00943396	0.7075471768867941
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00943396	0.7075471768867941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00943396	0.7075471768867941
HYDROLETHALUS	0.00943152	0.7073641768410442
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00943152	0.7073641768410442
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00943152	0.7073641768410442
JOUBERT SYNDROME WITH RENAL DEFECT	0.00943152	0.7073641768410442
6Q25 MICRODELETION SYNDROME	0.00943152	0.7073641768410442
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00943152	0.7073641768410442
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00943152	0.7073641768410442
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00943152	0.7073641768410442
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00943152	0.7073641768410442
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00943152	0.7073641768410442
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00943152	0.7073641768410442
MOSAIC TRISOMY 8	0.00943152	0.7073641768410442
HEREDITARY FOLATE MALABSORPTION	0.00941366	0.7060246765061691
TOXIC EPIDERMAL NECROLYSIS	0.00941366	0.7060246765061691
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00941366	0.7060246765061691
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00941366	0.7060246765061691
CASTLEMAN DISEASE	0.00941366	0.7060246765061691
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00941366	0.7060246765061691
EBOLA HEMORRHAGIC FEVER	0.00941366	0.7060246765061691
KAPOSIFORM LYMPHANGIOMATOSIS	0.0093741	0.7030576757644189
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0093741	0.7030576757644189
CHÉDIAK-HIGASHI SYNDROME	0.0093741	0.7030576757644189
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0093741	0.7030576757644189
OSTEOPETROSIS AND RELATED DISORDERS	0.0093741	0.7030576757644189
CHRONIC MYELOID LEUKEMIA	0.0093741	0.7030576757644189
1Q44 MICRODELETION SYNDROME	0.009313350000000001	0.6985014246253562
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.009313350000000001	0.6985014246253562
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.009313350000000001	0.6985014246253562
8P INVERTED DUPLICATION/DELETION SYNDROME	0.009313350000000001	0.6985014246253562
KLEEFSTRA SYNDROME	0.009313350000000001	0.6985014246253562
HOLOPROSENCEPHALY 11	0.009313350000000001	0.6985014246253562
TRISOMY 18-LIKE SYNDROME	0.00928239	0.696179424044856
EPILEPSY-TELANGIECTASIA	0.00916422	0.687316671829168
MONOSOMY 18P	0.00891917	0.6689379172344793
CAUDAL REGRESSION SEQUENCE	0.00891917	0.6689379172344793
ACROMEGALY	0.008801	0.6600751650187912
SOMATOMAMMOTROPINOMA	0.008801	0.6600751650187912
BEEMER-ERTBRUGGEN SYNDROME	0.0087732	0.6579901644975411
ROBERTS SYNDROME	0.0087732	0.6579901644975411
BEEMER LETHAL MALFORMATION SYNDROME	0.0087732	0.6579901644975411
HEMOCHROMATOSIS TYPE 4	0.00869565	0.6521739130434782
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00869565	0.6521739130434782
ALAGILLE SYNDROME 1; ALGS1	0.00869565	0.6521739130434782
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.00869565	0.6521739130434782
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00869565	0.6521739130434782
PORPHYRIA CUTANEA TARDA	0.00869565	0.6521739130434782
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.00869565	0.6521739130434782
RARE HEREDITARY HEMOCHROMATOSIS	0.00869565	0.6521739130434782
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00869565	0.6521739130434782
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00869565	0.6521739130434782
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00869565	0.6521739130434782
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00869565	0.6521739130434782
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.6521739130434782
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00869565	0.6521739130434782
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.6521739130434782
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00869565	0.6521739130434782
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.00869565	0.6521739130434782
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.6521739130434782
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.6521739130434782
GRACILE SYNDROME	0.00869565	0.6521739130434782
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.6521739130434782
HEMOCHROMATOSIS, TYPE 3; HFE3	0.00869565	0.6521739130434782
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.00869565	0.6521739130434782
CUTANEOUS MASTOCYTOSIS	0.00849904	0.6374281593570398
CHOREOACANTHOCYTOSIS	0.00849904	0.6374281593570398
MASTOCYTOSIS	0.00849904	0.6374281593570398
COLD AGGLUTININ DISEASE	0.00849904	0.6374281593570398
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00849904	0.6374281593570398
GALACTOSE EPIMERASE DEFICIENCY	0.00849904	0.6374281593570398
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00826446	0.6198346549586636
BRADDOCK SYNDROME	0.00826446	0.6198346549586636
PULMONARY HYPERTENSION, PRIMARY, 4	0.00826446	0.6198346549586636
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00826446	0.6198346549586636
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.00826446	0.6198346549586636
TETRASOMY 9P	0.00826446	0.6198346549586636
3Q29 MICRODELETION SYNDROME	0.00826446	0.6198346549586636
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00826446	0.6198346549586636
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00826446	0.6198346549586636
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00826446	0.6198346549586636
MELNICK-NEEDLES SYNDROME	0.00826446	0.6198346549586636
EISENMENGER SYNDROME	0.00826446	0.6198346549586636
CONGENITAL TRICUSPID STENOSIS	0.00826446	0.6198346549586636
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00826446	0.6198346549586636
SCIMITAR SYNDROME	0.00826446	0.6198346549586636
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00826446	0.6198346549586636
KEUTEL SYNDROME	0.00826446	0.6198346549586636
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.00826446	0.6198346549586636
COG1-CDG	0.00826446	0.6198346549586636
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.00826446	0.6198346549586636
YELLOW NAIL SYNDROME	0.00826446	0.6198346549586636
PULMONARY ARTERIOVENOUS MALFORMATION	0.00826446	0.6198346549586636
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00795307	0.5964803991200998
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00795307	0.5964803991200998
MONOSOMY 13Q14	0.00790415	0.5928113982028496
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00790415	0.5928113982028496
KOOLEN-DE VRIES SYNDROME; KDVS	0.00790415	0.5928113982028496
49,XXXXY SYNDROME	0.00790415	0.5928113982028496
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00790415	0.5928113982028496
17P11.2 MICRODUPLICATION SYNDROME	0.00790415	0.5928113982028496
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00778598	0.5839486459871615
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00778598	0.5839486459871615
CEREBROFACIOTHORACIC DYSPLASIA	0.00778598	0.5839486459871615
19P13.12 MICRODELETION SYNDROME	0.00778598	0.5839486459871615
AL KAISSI SYNDROME; ALKAS	0.00778598	0.5839486459871615
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00778598	0.5839486459871615
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00778598	0.5839486459871615
DESANTO-SHINAWI SYNDROME	0.00778598	0.5839486459871615
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00778598	0.5839486459871615
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00778598	0.5839486459871615
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00778598	0.5839486459871615
GOLDBERG-SHPRINTZEN SYNDROME	0.00778598	0.5839486459871615
PRIMROSE SYNDROME; PRIMS	0.00778598	0.5839486459871615
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.0077474	0.5810551452637863
HYPOPHOSPHATASIA, INFANTILE	0.0077474	0.5810551452637863
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.0077474	0.5810551452637863
PMM2-CDG	0.0077474	0.5810551452637863
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0077474	0.5810551452637863
INHALATIONAL ANTHRAX	0.0077474	0.5810551452637863
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.0077474	0.5810551452637863
POSTENCEPHALITIC PARKINSONISM	0.0077474	0.5810551452637863
RAT-BITE FEVER	0.0077474	0.5810551452637863
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.0077474	0.5810551452637863
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.0077474	0.5810551452637863
ACROOSTEOLYSIS DOMINANT TYPE	0.00774041	0.5805308951327237
ZIMMERMANN-LABAND SYNDROME 1	0.00774041	0.5805308951327237
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00774041	0.5805308951327237
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00774041	0.5805308951327237
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00772489	0.5793668948417237
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00772489	0.5793668948417237
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00772489	0.5793668948417237
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00772489	0.5793668948417237
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00772489	0.5793668948417237
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00744072	0.5580541395135348
TSH-SECRETING PITUITARY ADENOMA	0.00744072	0.5580541395135348
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00744072	0.5580541395135348
OROFACIODIGITAL SYNDROME TYPE 1	0.007361670000000001	0.552125388031347
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00729475	0.5471063867765966
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00729475	0.5471063867765966
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00729475	0.5471063867765966
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00729475	0.5471063867765966
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00729475	0.5471063867765966
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00729475	0.5471063867765966
HELLP SYNDROME	0.00729475	0.5471063867765966
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0072157	0.5411776352944088
JACOBSEN SYNDROME	0.0072157	0.5411776352944088
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00721254	0.5409406352351588
CONGENITAL ADRENAL HYPERPLASIA	0.00721254	0.5409406352351588
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.007156	0.5367001341750335
POSTORGASMIC ILLNESS SYNDROME	0.007156	0.5367001341750335
NEPHROBLASTOMA	0.007156	0.5367001341750335
CADASIL	0.007156	0.5367001341750335
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.007156	0.5367001341750335
TETANUS	0.007156	0.5367001341750335
STIFF-PERSON SYNDROME; SPS	0.007156	0.5367001341750335
ISOLATED AGAMMAGLOBULINEMIA	0.00701003	0.5257523814380953
AREGENERATIVE ANEMIA	0.00701003	0.5257523814380953
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00701003	0.5257523814380953
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00701003	0.5257523814380953
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.00701003	0.5257523814380953
ACUTE PROMYELOCYTIC LEUKEMIA	0.00701003	0.5257523814380953
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.00701003	0.5257523814380953
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00701003	0.5257523814380953
WISKOTT-ALDRICH SYNDROME	0.00701003	0.5257523814380953
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00670335	0.5027513756878439
ALPORT SYNDROME, X-LINKED; ATS	0.00670335	0.5027513756878439
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00670335	0.5027513756878439
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00670335	0.5027513756878439
PREECLAMPSIA/ECLAMPSIA 1	0.00670335	0.5027513756878439
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.0064256999999999995	0.4819276204819051
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.0064256999999999995	0.4819276204819051
HYPER-IGD SYNDROME	0.0063801299999999995	0.47850986962746733
NIEMANN-PICK DISEASE, TYPE A	0.0063801299999999995	0.47850986962746733
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0063801299999999995	0.47850986962746733
GALACTOSE EPIMERASE DEFICIENCY	0.0063801299999999995	0.47850986962746733
HYPERLIPOPROTEINEMIA, TYPE I	0.0063801299999999995	0.47850986962746733
OCULOCEREBROCUTANEOUS SYNDROME	0.0063466500000000006	0.4759988689997173
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0063466500000000006	0.4759988689997173
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0063466500000000006	0.4759988689997173
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0063466500000000006	0.4759988689997173
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0063466500000000006	0.4759988689997173
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0063466500000000006	0.4759988689997173
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0063466500000000006	0.4759988689997173
CRANIOFRONTONASAL SYNDROME; CFNS	0.0063466500000000006	0.4759988689997173
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0063466500000000006	0.4759988689997173
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0063466500000000006	0.4759988689997173
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0063466500000000006	0.4759988689997173
LISSENCEPHALY 3; LIS3	0.0063466500000000006	0.4759988689997173
BOHRING-OPITZ SYNDROME	0.0063466500000000006	0.4759988689997173
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0063466500000000006	0.4759988689997173
MICROPHTHALMIA, SYNDROMIC 3	0.0063466500000000006	0.4759988689997173
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.0063466500000000006	0.4759988689997173
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0063466500000000006	0.4759988689997173
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0063466500000000006	0.4759988689997173
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0063466500000000006	0.4759988689997173
GABRIELE-DE VRIES SYNDROME	0.0063466500000000006	0.4759988689997173
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0063466500000000006	0.4759988689997173
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0063466500000000006	0.4759988689997173
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.006301080000000001	0.47258111814527953
SIMPSON-GOLABI-BEHMEL SYNDROME	0.006301080000000001	0.47258111814527953
DESMOSTEROLOSIS	0.006301080000000001	0.47258111814527953
MECKEL SYNDROME, TYPE 1; MKS1	0.006301080000000001	0.47258111814527953
EMANUEL SYNDROME	0.00619752	0.464814116203529
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00615195	0.4613963653490913
REFSUM DISEASE	0.00615195	0.4613963653490913
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.4601228650307162
HALL-RIGGS SYNDROME	0.00613497	0.4601228650307162
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.4601228650307162
ADENOCARCINOMA OF THE ESOPHAGUS	0.00613497	0.4601228650307162
ATYPICAL TERATOID RHABDOID TUMOR	0.00613497	0.4601228650307162
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.4601228650307162
HYDATIDIFORM MOLE	0.00613497	0.4601228650307162
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00613497	0.4601228650307162
PRIMARY PARATHYROID HYPERPLASIA	0.00613497	0.4601228650307162
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.4601228650307162
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.00613497	0.4601228650307162
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.4601228650307162
GRFOMA	0.00613497	0.4601228650307162
BENIGN FAMILIAL INFANTILE EPILEPSY	0.00613497	0.4601228650307162
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.4601228650307162
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00613497	0.4601228650307162
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00613497	0.4601228650307162
FOODBORNE BOTULISM	0.00613497	0.4601228650307162
SOMATOSTATINOMA	0.00613497	0.4601228650307162
VIPOMA	0.00613497	0.4601228650307162
ACUTE ADRENAL INSUFFICIENCY	0.00613497	0.4601228650307162
GLUCAGONOMA	0.00613497	0.4601228650307162
PPOMA	0.00613497	0.4601228650307162
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00613497	0.4601228650307162
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.4601228650307162
EPISODIC ATAXIA TYPE 6	0.00613497	0.4601228650307162
MULTIPLE CARBOXYLASE DEFICIENCY	0.00613497	0.4601228650307162
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00613497	0.4601228650307162
HIRSCHSPRUNG DISEASE	0.00613497	0.4601228650307162
INHALATIONAL BOTULISM	0.00613497	0.4601228650307162
CARCINOID SYNDROME	0.00613497	0.4601228650307162
MEDULLOBLASTOMA	0.00613497	0.4601228650307162
INTESTINAL BOTULISM	0.00613497	0.4601228650307162
MENKES DISEASE	0.00613497	0.4601228650307162
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.4601228650307162
CRANIOPHARYNGIOMA	0.00613497	0.4601228650307162
ADDISON DISEASE	0.00613497	0.4601228650307162
LYNCH SYNDROME	0.00613497	0.4601228650307162
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00613497	0.4601228650307162
PARATHYROID CARCINOMA	0.00613497	0.4601228650307162
WYBURN-MASON SYNDROME	0.00613497	0.4601228650307162
BOTULISM	0.00613497	0.4601228650307162
PSEUDOMYXOMA PERITONEI	0.00613497	0.4601228650307162
FAMILIAL PANCREATIC CARCINOMA	0.00613497	0.4601228650307162
FAMILIAL COLORECTAL CANCER TYPE X	0.00613497	0.4601228650307162
L1 SYNDROME	0.00613497	0.4601228650307162
LHERMITTE-DUCLOS DISEASE	0.00613497	0.4601228650307162
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.4601228650307162
CLASSIC GALACTOSEMIA	0.00613497	0.4601228650307162
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.4601228650307162
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00613497	0.4601228650307162
AMYOTROPHIC LATERAL SCLEROSIS	0.00613497	0.4601228650307162
PORPHYRIA VARIEGATA	0.00613497	0.4601228650307162
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00613497	0.4601228650307162
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.4601228650307162
CLASSIC PHENYLKETONURIA	0.00613497	0.4601228650307162
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00613497	0.4601228650307162
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00613497	0.4601228650307162
GALACTOSEMIA	0.00613497	0.4601228650307162
MENINGIOMA	0.00613497	0.4601228650307162
CENTRAL NEUROCYTOMA	0.00613497	0.4601228650307162
HEMANGIOBLASTOMA	0.00613497	0.4601228650307162
LIPOSARCOMA	0.00613497	0.4601228650307162
MALIGNANT ATROPHIC PAPULOSIS	0.00613497	0.4601228650307162
NON-HISTAMINIC ANGIOEDEMA	0.00613497	0.4601228650307162
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.4601228650307162
SEVERE COMBINED IMMUNODEFICIENCY	0.00609541	0.45715586428896604
HEREDITARY ELLIPTOCYTOSIS	0.00609541	0.45715586428896604
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00609541	0.45715586428896604
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00609541	0.45715586428896604
ALPHA-HEAVY CHAIN DISEASE	0.00609541	0.45715586428896604
HEREDITARY SPHEROCYTOSIS	0.00609541	0.45715586428896604
FOLLICULAR LYMPHOMA	0.00609541	0.45715586428896604
MUCKLE-WELLS SYNDROME	0.00609541	0.45715586428896604
GLYCOGEN STORAGE DISEASE II	0.00609541	0.45715586428896604
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00609541	0.45715586428896604
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00609541	0.45715586428896604
CLASSIC HODGKIN LYMPHOMA	0.00609541	0.45715586428896604
OMENN SYNDROME	0.00609541	0.45715586428896604
CHRONIC GRANULOMATOUS DISEASE	0.00609541	0.45715586428896604
MU-HEAVY CHAIN DISEASE	0.00609541	0.45715586428896604
SCHNITZLER SYNDROME	0.00609541	0.45715586428896604
MAJEED SYNDROME	0.00609541	0.45715586428896604
IMMUNODEFICIENCY 32B; IMD32B	0.00609541	0.45715586428896604
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00609541	0.45715586428896604
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00609541	0.45715586428896604
MANTLE CELL LYMPHOMA	0.00609541	0.45715586428896604
HODGKIN LYMPHOMA	0.00609541	0.45715586428896604
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00609541	0.45715586428896604
WALDENSTRÖM MACROGLOBULINEMIA	0.00609541	0.45715586428896604
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00609541	0.45715586428896604
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00609541	0.45715586428896604
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00609541	0.45715586428896604
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00609541	0.45715586428896604
JUVENILE IDIOPATHIC ARTHRITIS	0.00609541	0.45715586428896604
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00609541	0.45715586428896604
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0058343	0.4375726093931523
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00578873	0.43415485853871455
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00578873	0.43415485853871455
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00578873	0.43415485853871455
THROMBOCYTHEMIA, ESSENTIAL	0.00578873	0.43415485853871455
HURLER SYNDROME	0.00578873	0.43415485853871455
SICKLE CELL ANEMIA	0.00578873	0.43415485853871455
LCAT DEFICIENCY	0.00578873	0.43415485853871455
TRIMETHYLAMINURIA	0.00578873	0.43415485853871455
COCKAYNE SYNDROME A; CSA	0.00578873	0.43415485853871455
16Q24.3 MICRODELETION SYNDROME	0.00568833	0.42662485665621414
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00568833	0.42662485665621414
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00568833	0.42662485665621414
CONGENITAL RUBELLA SYNDROME	0.00564276	0.42320710580177645
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00564276	0.42320710580177645
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00564276	0.42320710580177645
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00564276	0.42320710580177645
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00564276	0.42320710580177645
SEA-BLUE HISTIOCYTOSIS	0.00564276	0.42320710580177645
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00564276	0.42320710580177645
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00564276	0.42320710580177645
GRAY PLATELET SYNDROME	0.00564276	0.42320710580177645
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00564276	0.42320710580177645
GAUCHER DISEASE, PERINATAL LETHAL	0.00564276	0.42320710580177645
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00564276	0.42320710580177645
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00564276	0.42320710580177645
IMMUNODEFICIENCY 52; IMD52	0.00564276	0.42320710580177645
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.00564276	0.42320710580177645
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00564276	0.42320710580177645
AICARDI-GOUTIERES SYNDROME 7	0.00564276	0.42320710580177645
GAUCHER DISEASE, TYPE II	0.00564276	0.42320710580177645
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00564276	0.42320710580177645
FETAL GAUCHER DISEASE	0.00564276	0.42320710580177645
FELTY SYNDROME	0.00564276	0.42320710580177645
48,XXXY SYNDROME	0.00549451	0.41208835302208824
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.41208835302208824
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00549451	0.41208835302208824
THALIDOMIDE EMBRYOPATHY	0.00549451	0.41208835302208824
15Q11Q13 MICRODUPLICATION SYNDROME	0.00549451	0.41208835302208824
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00549451	0.41208835302208824
LAURENCE-MOON SYNDROME	0.00549451	0.41208835302208824
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.41208835302208824
MONOSOMY 5P	0.00549451	0.41208835302208824
DUANE RETRACTION SYNDROME	0.00549451	0.41208835302208824
ACHONDROGENESIS	0.00549451	0.41208835302208824
ACHONDROGENESIS TYPE 2	0.00549451	0.41208835302208824
ACHONDROGENESIS TYPE 1B	0.00549451	0.41208835302208824
ACROCRANIOFACIAL DYSOSTOSIS	0.00549451	0.41208835302208824
15Q26 OVERGROWTH SYNDROME	0.00549451	0.41208835302208824
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00549451	0.41208835302208824
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00549451	0.41208835302208824
ACHONDROGENESIS TYPE 1A	0.00549451	0.41208835302208824
AARSKOG-SCOTT SYNDROME	0.00549451	0.41208835302208824
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.41208835302208824
ERYTHROKERATODERMIA VARIABILIS	0.00549451	0.41208835302208824
ACALVARIA	0.00549451	0.41208835302208824
AUROCEPHALOSYNDACTYLY	0.00549451	0.41208835302208824
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00549451	0.41208835302208824
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.41208835302208824
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.41208835302208824
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00549451	0.41208835302208824
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00549451	0.41208835302208824
KEIPERT SYNDROME	0.00549451	0.41208835302208824
MARSHALL-SMITH SYNDROME	0.00549451	0.41208835302208824
NEUROFACIODIGITORENAL SYNDROME	0.00549451	0.41208835302208824
TRISOMY 20P	0.00549451	0.41208835302208824
KALLMANN SYNDROME	0.00549451	0.41208835302208824
OHDO SYNDROME	0.00549451	0.41208835302208824
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.41208835302208824
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00549451	0.41208835302208824
INIENCEPHALY	0.00549451	0.41208835302208824
SCHISIS ASSOCIATION	0.00549451	0.41208835302208824
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.41208835302208824
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00549451	0.41208835302208824
OROFACIODIGITAL SYNDROME TYPE 4	0.00549451	0.41208835302208824
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.41208835302208824
ANTLEY-BIXLER SYNDROME	0.00549451	0.41208835302208824
PHENYLKETONURIA	0.00549451	0.41208835302208824
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.41208835302208824
X-LINKED EHLERS-DANLOS SYNDROME	0.00549451	0.41208835302208824
AXENFELD-RIEGER SYNDROME	0.00549451	0.41208835302208824
RUBINSTEIN-TAYBI SYNDROME	0.00549451	0.41208835302208824
WEAVER SYNDROME	0.00549451	0.41208835302208824
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00549451	0.41208835302208824
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.41208835302208824
NAGER SYNDROME	0.00549451	0.41208835302208824
SAETHRE-CHOTZEN SYNDROME	0.00549451	0.41208835302208824
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.41208835302208824
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.41208835302208824
ISOLATED SPINA BIFIDA	0.00549451	0.41208835302208824
VACTERL WITH HYDROCEPHALUS	0.00549451	0.41208835302208824
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.41208835302208824
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00549451	0.41208835302208824
DISTAL TRISOMY 15Q	0.00549451	0.41208835302208824
48,XXYY SYNDROME	0.00549451	0.41208835302208824
ISOLATED HEMIHYPERPLASIA	0.00549451	0.41208835302208824
NON-DISTAL TRISOMY 10Q	0.00549451	0.41208835302208824
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.41208835302208824
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.41208835302208824
DISTAL MONOSOMY 10P	0.00549451	0.41208835302208824
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.41208835302208824
LARYNX ATRESIA	0.00549451	0.41208835302208824
TRISOMY 8Q	0.00549451	0.41208835302208824
TRISOMY 4P	0.00549451	0.41208835302208824
6Q16 MICRODELETION SYNDROME	0.00549451	0.41208835302208824
DISTAL TRISOMY 18Q	0.00549451	0.41208835302208824
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.41208835302208824
TRISOMY 18P	0.00549451	0.41208835302208824
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00549451	0.41208835302208824
CAMPOMELIC DYSPLASIA	0.00549451	0.41208835302208824
FRASER SYNDROME	0.00549451	0.41208835302208824
MOSAIC TRISOMY 14	0.00549451	0.41208835302208824
BARTSOCAS-PAPAS SYNDROME	0.00549451	0.41208835302208824
HEART-HAND SYNDROME TYPE 2	0.00549451	0.41208835302208824
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00549451	0.41208835302208824
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00549451	0.41208835302208824
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.41208835302208824
CAT-EYE SYNDROME	0.00549451	0.41208835302208824
HALLERMANN-STREIFF SYNDROME	0.00549451	0.41208835302208824
CAMPOMELIA, CUMMING TYPE	0.00549451	0.41208835302208824
DISTAL MONOSOMY 9P	0.00549451	0.41208835302208824
TRISOMY 12P	0.00549451	0.41208835302208824
RENAL AGENESIS, BILATERAL	0.00549451	0.41208835302208824
BOWEN-CONRADI SYNDROME	0.00549451	0.41208835302208824
DUPLICATION/INVERSION 15Q11	0.00537634	0.40322560080640024
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00537634	0.40322560080640024
GERMAN SYNDROME	0.00537634	0.40322560080640024
BARATELA-SCOTT SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.40322560080640024
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, X-LINKED 21	0.00537634	0.40322560080640024
GASTROCUTANEOUS SYNDROME	0.00537634	0.40322560080640024
HOLOPROSENCEPHALY 5; HPE5	0.00537634	0.40322560080640024
FOUNTAIN SYNDROME	0.00537634	0.40322560080640024
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00537634	0.40322560080640024
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.40322560080640024
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.40322560080640024
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.40322560080640024
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.40322560080640024
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.40322560080640024
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.40322560080640024
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.40322560080640024
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.40322560080640024
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.40322560080640024
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00537634	0.40322560080640024
2Q31.1 MICRODELETION SYNDROME	0.00537634	0.40322560080640024
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00537634	0.40322560080640024
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00537634	0.40322560080640024
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00537634	0.40322560080640024
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.40322560080640024
WAARDENBURG-SHAH SYNDROME	0.00537634	0.40322560080640024
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00537634	0.40322560080640024
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00537634	0.40322560080640024
FETAL TRIMETHADIONE SYNDROME	0.00537634	0.40322560080640024
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.40322560080640024
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.40322560080640024
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.40322560080640024
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00537634	0.40322560080640024
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.40322560080640024
20P13 MICRODELETION SYNDROME	0.00537634	0.40322560080640024
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00537634	0.40322560080640024
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.40322560080640024
PIEBALDISM	0.00537634	0.40322560080640024
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.40322560080640024
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.40322560080640024
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.40322560080640024
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00537634	0.40322560080640024
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00537634	0.40322560080640024
11P15.4 MICRODUPLICATION SYNDROME	0.00537634	0.40322560080640024
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00537634	0.40322560080640024
WAARDENBURG SYNDROME	0.00537634	0.40322560080640024
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00537634	0.40322560080640024
ISOLATED TRIGONOCEPHALY	0.00537634	0.40322560080640024
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00537634	0.40322560080640024
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.40322560080640024
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00537634	0.40322560080640024
XYLT1-CDG	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00537634	0.40322560080640024
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00537634	0.40322560080640024
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00537634	0.40322560080640024
17Q24.2 MICRODELETION SYNDROME	0.00537634	0.40322560080640024
MCDONOUGH SYNDROME	0.00537634	0.40322560080640024
2Q23.1 MICRODELETION SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00537634	0.40322560080640024
17Q21.31 MICRODUPLICATION SYNDROME	0.00537634	0.40322560080640024
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00537634	0.40322560080640024
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00537634	0.40322560080640024
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00537634	0.40322560080640024
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00537634	0.40322560080640024
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00537634	0.40322560080640024
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00537634	0.40322560080640024
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.40322560080640024
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00537634	0.40322560080640024
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.40322560080640024
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.40322560080640024
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.40322560080640024
BRANCHIOSKELETOGENITAL SYNDROME	0.00537634	0.40322560080640024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.00537634	0.40322560080640024
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00537634	0.40322560080640024
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.00537634	0.40322560080640024
KBG SYNDROME	0.00537634	0.40322560080640024
ELSAHY-WATERS SYNDROME; ESWS	0.00537634	0.40322560080640024
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.40322560080640024
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.40322560080640024
MONOSOMY 22	0.00537634	0.40322560080640024
NON-DISTAL MONOSOMY 10Q	0.00537634	0.40322560080640024
KLEEFSTRA SYNDROME	0.00537634	0.40322560080640024
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00537634	0.40322560080640024
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.3012045753011438
PEUTZ-JEGHERS SYNDROME	0.00401606	0.3012045753011438
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.3012045753011438
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00401606	0.3012045753011438
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00401606	0.3012045753011438
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00401606	0.3012045753011438
ACQUIRED METHEMOGLOBINEMIA	0.00401606	0.3012045753011438
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00401606	0.3012045753011438
CHYLOMICRON RETENTION DISEASE	0.00401606	0.3012045753011438
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00401606	0.3012045753011438
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00401606	0.3012045753011438
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.3012045753011438
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00401606	0.3012045753011438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00401606	0.3012045753011438
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00401606	0.3012045753011438
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00401606	0.3012045753011438
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.3012045753011438
VALINEMIA	0.00401606	0.3012045753011438
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.3012045753011438
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00401606	0.3012045753011438
CHYLOMICRON RETENTION DISEASE	0.00401606	0.3012045753011438
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00401606	0.3012045753011438
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.3012045753011438
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.3012045753011438
VISCERAL MYOPATHY; VSCM	0.00401606	0.3012045753011438
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.3012045753011438
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00401606	0.3012045753011438
PANCREATOBLASTOMA	0.00401606	0.3012045753011438
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.3012045753011438
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00401606	0.3012045753011438
HEREDITARY FRUCTOSE INTOLERANCE	0.00401606	0.3012045753011438
ARGININOSUCCINIC ACIDURIA	0.00401606	0.3012045753011438
PORPHYRIA VARIEGATA	0.00401606	0.3012045753011438
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.3012045753011438
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00401606	0.3012045753011438
CONGENITAL PANCREATIC CYST	0.00401606	0.3012045753011438
SPINOCEREBELLAR ATAXIA TYPE 25	0.00401606	0.3012045753011438
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.3012045753011438
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00401606	0.3012045753011438
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.3012045753011438
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00401606	0.3012045753011438
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00401606	0.3012045753011438
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00401606	0.3012045753011438
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00401606	0.3012045753011438
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.3012045753011438
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.3012045753011438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.00401606	0.3012045753011438
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.3012045753011438
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.3012045753011438
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00401606	0.3012045753011438
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00401606	0.3012045753011438
13Q12.3 MICRODELETION SYNDROME	0.00401606	0.3012045753011438
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.3012045753011438
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.3012045753011438
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.3012045753011438
PAPILLOMA OF CHOROID PLEXUS	0.00401606	0.3012045753011438
PROLACTINOMA	0.00401606	0.3012045753011438
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00401606	0.3012045753011438
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00401606	0.3012045753011438
ATRESIA OF SMALL INTESTINE	0.00401606	0.3012045753011438
ESOPHAGEAL ATRESIA	0.00401606	0.3012045753011438
CYCLIC VOMITING SYNDROME	0.00401606	0.3012045753011438
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.3012045753011438
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00401606	0.3012045753011438
MAPLE SYRUP URINE DISEASE; MSUD	0.00401606	0.3012045753011438
LARYNGOTRACHEAL ANGIOMA	0.00401606	0.3012045753011438
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.3012045753011438
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00401606	0.3012045753011438
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.3012045753011438
DEND SYNDROME	0.00401606	0.3012045753011438
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.3012045753011438
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00401606	0.3012045753011438
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.3012045753011438
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.3012045753011438
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00401606	0.3012045753011438
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.3012045753011438
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.3012045753011438
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.3012045753011438
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.3012045753011438
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.00401606	0.3012045753011438
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00401606	0.3012045753011438
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00401606	0.3012045753011438
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00401606	0.3012045753011438
EPISODIC ATAXIA, TYPE 3	0.00401606	0.3012045753011438
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00401606	0.3012045753011438
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.3012045753011438
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.3012045753011438
NON-FUNCTIONING PITUITARY ADENOMA	0.00401606	0.3012045753011438
SECONDARY SHORT BOWEL SYNDROME	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.3012045753011438
MÉNÉTRIER DISEASE	0.00401606	0.3012045753011438
OPTIC PATHWAY GLIOMA	0.00401606	0.3012045753011438
HYPERCALCEMIA, INFANTILE, 1	0.00401606	0.3012045753011438
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00401606	0.3012045753011438
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00401606	0.3012045753011438
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.3012045753011438
BENIGN OCCIPITAL EPILEPSY	0.00401606	0.3012045753011438
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00401606	0.3012045753011438
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00401606	0.3012045753011438
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.3012045753011438
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00401606	0.3012045753011438
EPISODIC ATAXIA, TYPE 6	0.00401606	0.3012045753011438
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.3012045753011438
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.3012045753011438
EPENDYMOMA	0.00401606	0.3012045753011438
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00401606	0.3012045753011438
SUBEPENDYMOMA	0.00401606	0.3012045753011438
MYXOPAPILLARY EPENDYMOMA	0.00401606	0.3012045753011438
TURCOT SYNDROME WITH POLYPOSIS	0.00401606	0.3012045753011438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00401606	0.3012045753011438
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.3012045753011438
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.3012045753011438
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00401606	0.3012045753011438
HENNEKAM-BEEMER SYNDROME	0.00401606	0.3012045753011438
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00401606	0.3012045753011438
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.3012045753011438
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00393701	0.29527582381895595
FRYNS SYNDROME	0.00393701	0.29527582381895595
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00393701	0.29527582381895595
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.00393701	0.29527582381895595
AMISH LETHAL MICROCEPHALY	0.00393701	0.29527582381895595
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00393701	0.29527582381895595
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00393701	0.29527582381895595
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00393701	0.29527582381895595
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.00393701	0.29527582381895595
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00393701	0.29527582381895595
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.00393701	0.29527582381895595
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00393701	0.29527582381895595
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00393701	0.29527582381895595
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00393701	0.29527582381895595
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00393701	0.29527582381895595
MOSAIC TRISOMY 1	0.00393701	0.29527582381895595
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00393701	0.29527582381895595
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00393701	0.29527582381895595
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00393701	0.29527582381895595
1Q21.1 MICRODELETION SYNDROME	0.00393701	0.29527582381895595
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00393701	0.29527582381895595
AGNATHIA-OTOCEPHALY COMPLEX	0.00393701	0.29527582381895595
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00393701	0.29527582381895595
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00393701	0.29527582381895595
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00393701	0.29527582381895595
DUPLICATION OF THE PITUITARY GLAND	0.00393701	0.29527582381895595
FOCAL DERMAL HYPOPLASIA; FDH	0.00393701	0.29527582381895595
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00393701	0.29527582381895595
MASA SYNDROME	0.00393701	0.29527582381895595
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00393701	0.29527582381895595
CHIARI MALFORMATION TYPE II	0.00393701	0.29527582381895595
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00393701	0.29527582381895595
MASA SYNDROME	0.00393701	0.29527582381895595
MECKEL SYNDROME 12; MKS12	0.00393701	0.29527582381895595
HARTSFIELD SYNDROME; HRTFDS	0.00393701	0.29527582381895595
OTOMANDIBULAR SYNDROME	0.00393701	0.29527582381895595
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00393701	0.29527582381895595
CURRY-JONES SYNDROME	0.00393701	0.29527582381895595
GOLDENHAR SYNDROME	0.00393701	0.29527582381895595
CRANIOTELENCEPHALIC DYSPLASIA	0.00393701	0.29527582381895595
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00393701	0.29527582381895595
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00393701	0.29527582381895595
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00393701	0.29527582381895595
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00393701	0.29527582381895595
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.00393701	0.29527582381895595
VICI SYNDROME	0.00393701	0.29527582381895595
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00393701	0.29527582381895595
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00393701	0.29527582381895595
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.00393701	0.29527582381895595
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00393701	0.29527582381895595
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00393701	0.29527582381895595
CRANIOTELENCEPHALIC DYSPLASIA	0.00393701	0.29527582381895595
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00393701	0.29527582381895595
RING CHROMOSOME 22 SYNDROME	0.00393701	0.29527582381895595
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00393701	0.29527582381895595
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00393701	0.29527582381895595
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.29527582381895595
RING CHROMOSOME 13 SYNDROME	0.00393701	0.29527582381895595
SCHIZENCEPHALY	0.00393701	0.29527582381895595
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00393701	0.29527582381895595
MARDEN-WALKER SYNDROME	0.00393701	0.29527582381895595
OROFACIODIGITAL SYNDROME XV; OFD15	0.00393701	0.29527582381895595
MARDEN-WALKER SYNDROME	0.00393701	0.29527582381895595
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00393701	0.29527582381895595
LISSENCEPHALY, X-LINKED, 2	0.00393701	0.29527582381895595
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.00393701	0.29527582381895595
HOLOPROSENCEPHALY 7	0.00393701	0.29527582381895595
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00393701	0.29527582381895595
FETAL AKINESIA SYNDROME, X-LINKED	0.00393701	0.29527582381895595
LISSENCEPHALY, X-LINKED, 1; LISX1	0.00393701	0.29527582381895595
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00393701	0.29527582381895595
EMANUEL SYNDROME	0.00393701	0.29527582381895595
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.29527582381895595
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00393701	0.29527582381895595
GABA-TRANSAMINASE DEFICIENCY	0.00393701	0.29527582381895595
3Q13 MICRODELETION SYNDROME	0.00393701	0.29527582381895595
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00393701	0.29527582381895595
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00393701	0.29527582381895595
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00393701	0.29527582381895595
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00393701	0.29527582381895595
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00393701	0.29527582381895595
MONOSOMY 13Q34	0.00393701	0.29527582381895595
CRANIOSYNOSTOSIS 6; CRS6	0.00393701	0.29527582381895595
TEMTAMY SYNDROME; TEMTYS	0.00393701	0.29527582381895595
JABERI-ELAHI SYNDROME; JABELS	0.00393701	0.29527582381895595
TRISOMY 1Q	0.00393701	0.29527582381895595
BAND HETEROTOPIA; BH	0.00393701	0.29527582381895595
LISSENCEPHALY 4	0.00393701	0.29527582381895595
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00393701	0.29527582381895595
HOLOPROSENCEPHALY 2; HPE2	0.00393701	0.29527582381895595
GENITOPATELLAR SYNDROME; GTPTS	0.00393701	0.29527582381895595
OROFACIODIGITAL SYNDROME TYPE 5	0.00393701	0.29527582381895595
VICI SYNDROME; VICIS	0.00393701	0.29527582381895595
WOLF-HIRSCHHORN SYNDROME	0.00393701	0.29527582381895595
SEPTOOPTIC DYSPLASIA	0.00393701	0.29527582381895595
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00393701	0.29527582381895595
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.29527582381895595
THAKKER-DONNAI SYNDROME	0.00393701	0.29527582381895595
HOLOPROSENCEPHALY 1; HPE1	0.00393701	0.29527582381895595
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00393701	0.29527582381895595
OROFACIODIGITAL SYNDROME V; OFD5	0.00393701	0.29527582381895595
16P13.11 MICRODELETION SYNDROME	0.00393701	0.29527582381895595
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00393701	0.29527582381895595
HEMIFACIAL MICROSOMIA	0.00393701	0.29527582381895595
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00393701	0.29527582381895595
14Q12 MICRODELETION SYNDROME	0.00393701	0.29527582381895595
HYDROLETHALUS SYNDROME 1	0.00393701	0.29527582381895595
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00393701	0.29527582381895595
GENITOPATELLAR SYNDROME	0.00393701	0.29527582381895595
FUMARASE DEFICIENCY; FMRD	0.00393701	0.29527582381895595
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00393701	0.29527582381895595
TOWNES-BROCKS SYNDROME	0.00393701	0.29527582381895595
CURRY-JONES SYNDROME	0.00393701	0.29527582381895595
ACROMELIC FRONTONASAL DYSPLASIA	0.00393701	0.29527582381895595
MICROFORM HOLOPROSENCEPHALY	0.00393701	0.29527582381895595
FRYNS SYNDROME; FRNS	0.00393701	0.29527582381895595
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00393701	0.29527582381895595
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00393701	0.29527582381895595
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00393701	0.29527582381895595
TRISOMY 8P	0.00393701	0.29527582381895595
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00393701	0.29527582381895595
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00393701	0.29527582381895595
MICROHYDRANENCEPHALY; MHAC	0.00393701	0.29527582381895595
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00393701	0.29527582381895595
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00393701	0.29527582381895595
STROMME SYNDROME; STROMS	0.00393701	0.29527582381895595
WALKER-WARBURG SYNDROME	0.00393701	0.29527582381895595
14Q22Q23 MICRODELETION SYNDROME	0.00393701	0.29527582381895595
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.28409107102276776
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.28409107102276776
HOOFT DISEASE	0.00378788	0.28409107102276776
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.28409107102276776
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.28409107102276776
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.28409107102276776
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.28409107102276776
BARTTER SYNDROME	0.00378788	0.28409107102276776
NEPHROSIALIDOSIS	0.00378788	0.28409107102276776
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.28409107102276776
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.28409107102276776
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.28409107102276776
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.28409107102276776
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.28409107102276776
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.28409107102276776
PENDRED SYNDROME	0.00378788	0.28409107102276776
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.28409107102276776
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.28409107102276776
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.28409107102276776
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.28409107102276776
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.28409107102276776
XANTHINURIA, TYPE I	0.00378788	0.28409107102276776
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.28409107102276776
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.28409107102276776
PACMAN DYSPLASIA	0.00378788	0.28409107102276776
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.28409107102276776
ASPARTYLGLUCOSAMINURIA; AGU	0.00378788	0.28409107102276776
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.28409107102276776
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.28409107102276776
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.28409107102276776
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.28409107102276776
OVARIAN CANCER	0.00378788	0.28409107102276776
APOLIPOPROTEIN(A)	0.00378788	0.28409107102276776
GAPO SYNDROME; GAPOS	0.00378788	0.28409107102276776
OSTEOMESOPYKNOSIS	0.00378788	0.28409107102276776
T-SUBSTANCE ANOMALY	0.00378788	0.28409107102276776
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.28409107102276776
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.28409107102276776
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.28409107102276776
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.28409107102276776
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.28409107102276776
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	0.28409107102276776
DERMATITIS, ATOPIC	0.00378788	0.28409107102276776
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.28409107102276776
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.28409107102276776
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.28409107102276776
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.28409107102276776
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.28409107102276776
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.28409107102276776
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.28409107102276776
OSTEOGENIC SARCOMA	0.00378788	0.28409107102276776
DERMATOLEUKODYSTROPHY	0.00378788	0.28409107102276776
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.28409107102276776
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.28409107102276776
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.28409107102276776
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.28409107102276776
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.28409107102276776
SALLA DISEASE	0.00378788	0.28409107102276776
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.28409107102276776
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.28409107102276776
CITRULLINE TRANSPORT DEFECT	0.00378788	0.28409107102276776
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.28409107102276776
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.28409107102276776
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.28409107102276776
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.28409107102276776
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.28409107102276776
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	0.28409107102276776
LARON SYNDROME	0.00378788	0.28409107102276776
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.28409107102276776
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.28409107102276776
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.28409107102276776
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.28409107102276776
REVESZ SYNDROME	0.00378788	0.28409107102276776
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.28409107102276776
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	0.28409107102276776
PYGMY	0.00378788	0.28409107102276776
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.28409107102276776
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.28409107102276776
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.28409107102276776
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.28409107102276776
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.28409107102276776
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.28409107102276776
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.28409107102276776
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.28409107102276776
PROGESTERONE RESISTANCE	0.00378788	0.28409107102276776
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.28409107102276776
PITUITARY DWARFISM IV	0.00378788	0.28409107102276776
XYLOSIDASE DEFICIENCY	0.00378788	0.28409107102276776
CUTIS LAXA	0.00378788	0.28409107102276776
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.28409107102276776
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.28409107102276776
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.28409107102276776
GLUTATHIONURIA	0.00378788	0.28409107102276776
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.28409107102276776
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.28409107102276776
BEETURIA	0.00378788	0.28409107102276776
GLUTATHIONE REDUCTASE	0.00378788	0.28409107102276776
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.28409107102276776
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.28409107102276776
SPINAL ARACHNOIDITIS	0.00378788	0.28409107102276776
FINGERPRINT BODY MYOPATHY	0.00378788	0.28409107102276776
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.28409107102276776
GLOMUVENOUS MALFORMATIONS	0.00378788	0.28409107102276776
ZINC, ELEVATED PLASMA	0.00378788	0.28409107102276776
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.28409107102276776
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.28409107102276776
MYOPATHY, SPHEROID BODY	0.00378788	0.28409107102276776
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.28409107102276776
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.28409107102276776
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.28409107102276776
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.28409107102276776
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.28409107102276776
CALVARIAL HYPEROSTOSIS	0.00378788	0.28409107102276776
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.28409107102276776
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.28409107102276776
LIPASE DEFICIENCY, COMBINED	0.00378788	0.28409107102276776
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00378788	0.28409107102276776
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.28409107102276776
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.28409107102276776
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.28409107102276776
ICHTHYOSIS, X-LINKED	0.00378788	0.28409107102276776
GONADOBLASTOMA	0.00378788	0.28409107102276776
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.28409107102276776
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	0.28409107102276776
HEINZ BODY ANEMIAS	0.00378788	0.28409107102276776
DELETED IN AZOOSPERMIA	0.00378788	0.28409107102276776
LARSEN-LIKE SYNDROME	0.00378788	0.28409107102276776
XM SYSTEM	0.00378788	0.28409107102276776
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.28409107102276776
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.28409107102276776
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.28409107102276776
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.28409107102276776
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.28409107102276776
ACETYLATION, SLOW	0.00378788	0.28409107102276776
ONCOCYTOMA	0.00378788	0.28409107102276776
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.28409107102276776
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.28409107102276776
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.28409107102276776
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.28409107102276776
PREMATURE OVARIAN FAILURE 1	0.00378788	0.28409107102276776
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.28409107102276776
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	0.28409107102276776
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.28409107102276776
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.28409107102276776
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.28409107102276776
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.28409107102276776
SCHIZOPHRENIA 4	0.00378788	0.28409107102276776
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.28409107102276776
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.28409107102276776
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.28409107102276776
LYMPHOKINE DEFICIENCY	0.00378788	0.28409107102276776
CHROMOSOME 10Q26 DELETION SYNDROME	0.00378788	0.28409107102276776
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.28409107102276776
HYPOASCORBEMIA	0.00378788	0.28409107102276776
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.28409107102276776
NEURONAL CEROID LIPOFUSCINOSIS	0.00378788	0.28409107102276776
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.28409107102276776
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.28409107102276776
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.28409107102276776
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.28409107102276776
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	0.28409107102276776
PARAOXONASE 1	0.00378788	0.28409107102276776
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.28409107102276776
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.28409107102276776
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.28409107102276776
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	0.28409107102276776
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.28409107102276776
AREDYLD	0.00378788	0.28409107102276776
PERRY SYNDROME	0.00378788	0.28409107102276776
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.28409107102276776
HYPERPROGLUCAGONEMIA	0.00378788	0.28409107102276776
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.28409107102276776
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.28409107102276776
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.28409107102276776
46,XX GONADAL DYSGENESIS	0.00378788	0.28409107102276776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.28409107102276776
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.28409107102276776
ETHANOLAMINOSIS	0.00378788	0.28409107102276776
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.28409107102276776
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.28409107102276776
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.28409107102276776
MACULAR CORNEAL DYSTROPHY	0.00378788	0.28409107102276776
ALKAPTONURIA	0.00378788	0.28409107102276776
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.28409107102276776
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.28409107102276776
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.28409107102276776
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.28409107102276776
CARBOXYLESTERASE 1	0.00378788	0.28409107102276776
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.28409107102276776
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.28409107102276776
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.28409107102276776
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.28409107102276776
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.28409107102276776
ALAND ISLAND EYE DISEASE	0.00378788	0.28409107102276776
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.28409107102276776
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00373134	0.27985056996264246
CAFFEY DISEASE	0.00373134	0.27985056996264246
PONTIAC FEVER	0.00373134	0.27985056996264246
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00373134	0.27985056996264246
PYODERMA GANGRENOSUM	0.00373134	0.27985056996264246
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00373134	0.27985056996264246
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.00373134	0.27985056996264246
KERION CELSI	0.00373134	0.27985056996264246
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00373134	0.27985056996264246
MACROPHAGIC MYOFASCIITIS	0.00373134	0.27985056996264246
ACUTE MONOBLASTIC LEUKEMIA	0.00373134	0.27985056996264246
LYMPHANGIOLEIOMYOMATOSIS	0.00373134	0.27985056996264246
MALAKOPLAKIA	0.00373134	0.27985056996264246
CAFFEY DISEASE	0.00373134	0.27985056996264246
FEVER, FAMILIAL LIFELONG PERSISTENT	0.00373134	0.27985056996264246
FOCAL MYOSITIS	0.00373134	0.27985056996264246
KRABBE DISEASE	0.00373134	0.27985056996264246
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00373134	0.27985056996264246
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00373134	0.27985056996264246
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00373134	0.27985056996264246
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.00373134	0.27985056996264246
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00373134	0.27985056996264246
KLATSKIN TUMOR	0.00373134	0.27985056996264246
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00373134	0.27985056996264246
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00373134	0.27985056996264246
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.00373134	0.27985056996264246
POLYMYOSITIS	0.00373134	0.27985056996264246
PSORIASIS 14, PUSTULAR	0.00373134	0.27985056996264246
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00373134	0.27985056996264246
PANCREATITIS, HEREDITARY	0.00373134	0.27985056996264246
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00373134	0.27985056996264246
RETICULAR DYSGENESIS	0.00373134	0.27985056996264246
CHOLANGIOCARCINOMA	0.00373134	0.27985056996264246
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.00373134	0.27985056996264246
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.00373134	0.27985056996264246
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00373134	0.27985056996264246
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00373134	0.27985056996264246
TUBERCULOSIS	0.00373134	0.27985056996264246
CYCLIC NEUTROPENIA	0.00373134	0.27985056996264246
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00373134	0.27985056996264246
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.27985056996264246
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00373134	0.27985056996264246
MELKERSSON-ROSENTHAL SYNDROME	0.00373134	0.27985056996264246
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00373134	0.27985056996264246
PYOMYOSITIS	0.00373134	0.27985056996264246
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00373134	0.27985056996264246
XERODERMA PIGMENTOSUM	0.00373134	0.27985056996264246
IDIOPATHIC BRONCHIECTASIS	0.00373134	0.27985056996264246
POLYEMBRYOMA	0.00373134	0.27985056996264246
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00373134	0.27985056996264246
CINCA SYNDROME; CINCA	0.00373134	0.27985056996264246
ROTOR SYNDROME	0.00373134	0.27985056996264246
JUVENILE DERMATOMYOSITIS	0.00373134	0.27985056996264246
KUFOR-RAKEB SYNDROME	0.00373134	0.27985056996264246
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.00373134	0.27985056996264246
WOUND BOTULISM	0.00373134	0.27985056996264246
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00373134	0.27985056996264246
REACTIVE ARTHRITIS	0.00373134	0.27985056996264246
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00373134	0.27985056996264246
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00373134	0.27985056996264246
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00373134	0.27985056996264246
PULMONARY BLASTOMA	0.00373134	0.27985056996264246
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00373134	0.27985056996264246
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00373134	0.27985056996264246
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00373134	0.27985056996264246
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.27985056996264246
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00373134	0.27985056996264246
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00373134	0.27985056996264246
NEUROPATHY, PAINFUL	0.00373134	0.27985056996264246
ADULT IDIOPATHIC NEUTROPENIA	0.00373134	0.27985056996264246
PSEUDODIASTROPHIC DYSPLASIA	0.00373134	0.27985056996264246
CONGENITAL PRIMARY MEGAURETER	0.00373134	0.27985056996264246
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.00373134	0.27985056996264246
ROSAÏ-DORFMAN DISEASE	0.00373134	0.27985056996264246
OSTEOSARCOMA	0.00373134	0.27985056996264246
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00373134	0.27985056996264246
FAMILIAL ATRIAL MYXOMA	0.00373134	0.27985056996264246
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.00373134	0.27985056996264246
CUTANEOUS SMALL VESSEL VASCULITIS	0.00373134	0.27985056996264246
WELLS SYNDROME	0.00373134	0.27985056996264246
DYSTONIA 12; DYT12	0.00373134	0.27985056996264246
DUBIN-JOHNSON SYNDROME	0.00373134	0.27985056996264246
SECKEL SYNDROME 10; SCKL10	0.00342466	0.256849564212391
POTOCKI-SHAFFER SYNDROME	0.00342466	0.256849564212391
SNEDDON SYNDROME	0.00342466	0.256849564212391
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.256849564212391
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.256849564212391
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00342466	0.256849564212391
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00342466	0.256849564212391
FAMILIAL PSEUDOHYPERKALEMIA	0.00342466	0.256849564212391
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00342466	0.256849564212391
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.256849564212391
NEUROFIBROMATOSIS, TYPE I	0.00342466	0.256849564212391
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.256849564212391
POLYCYSTIC KIDNEYS	0.00342466	0.256849564212391
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.256849564212391
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00342466	0.256849564212391
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00342466	0.256849564212391
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.256849564212391
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00342466	0.256849564212391
ACTH-DEPENDENT CUSHING SYNDROME	0.00342466	0.256849564212391
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.256849564212391
ACTH-INDEPENDENT CUSHING SYNDROME	0.00342466	0.256849564212391
SNEDDON SYNDROME	0.00342466	0.256849564212391
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.256849564212391
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.256849564212391
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00342466	0.256849564212391
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00342466	0.256849564212391
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00342466	0.256849564212391
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00342466	0.256849564212391
ALAGILLE SYNDROME	0.00342466	0.256849564212391
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.256849564212391
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00342466	0.256849564212391
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00342466	0.256849564212391
ARTERIAL TORTUOSITY SYNDROME	0.00342466	0.256849564212391
WERNER SYNDROME	0.00342466	0.256849564212391
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00342466	0.256849564212391
BARDET-BIEDL SYNDROME 1; BBS1	0.00342466	0.256849564212391
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	0.00342466	0.256849564212391
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.256849564212391
BARDET-BIEDL SYNDROME	0.00342466	0.256849564212391
CUSHING SYNDROME	0.00342466	0.256849564212391
ALKAPTONURIA	0.00342466	0.256849564212391
CUSHING DISEASE	0.00342466	0.256849564212391
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00342466	0.256849564212391
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00342466	0.256849564212391
SECONDARY POLYCYTHEMIA	0.00342466	0.256849564212391
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00342466	0.256849564212391
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.256849564212391
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.256849564212391
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00342466	0.256849564212391
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00342466	0.256849564212391
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.256849564212391
POSTERIOR URETHRAL VALVE	0.00342466	0.256849564212391
PARAGANGLIOMAS 6	0.00342466	0.256849564212391
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.256849564212391
TUBEROUS SCLEROSIS COMPLEX	0.00342466	0.256849564212391
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00342466	0.256849564212391
ATYPICAL WERNER SYNDROME	0.00342466	0.256849564212391
MYHRE SYNDROME	0.00342466	0.256849564212391
GRANGE SYNDROME	0.00342466	0.256849564212391
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00342466	0.256849564212391
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00342466	0.256849564212391
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00342466	0.256849564212391
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00342466	0.256849564212391
POPOV-CHANG SYNDROME; POPCHAS	0.00342466	0.256849564212391
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.256849564212391
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00342466	0.256849564212391
PRIMARY PROGRESSIVE FREEZING GAIT	0.00342466	0.256849564212391
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.00342466	0.256849564212391
LIDDLE SYNDROME	0.00342466	0.256849564212391
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00342466	0.256849564212391
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00342466	0.256849564212391
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00342466	0.256849564212391
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.256849564212391
DENYS-DRASH SYNDROME	0.00342466	0.256849564212391
GLYCOGEN STORAGE DISEASE IA	0.00342466	0.256849564212391
JUVENILE PAGET DISEASE	0.00342466	0.256849564212391
RENAL AGENESIS	0.00342466	0.256849564212391
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00342466	0.256849564212391
OCHOA SYNDROME	0.00342466	0.256849564212391
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00342466	0.256849564212391
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00342466	0.256849564212391
COCKAYNE SYNDROME	0.00342466	0.256849564212391
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00342466	0.256849564212391
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00342466	0.256849564212391
ISOLATED ECTOPIA LENTIS	0.00342466	0.256849564212391
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00342466	0.256849564212391
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.256849564212391
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00342466	0.256849564212391
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00342466	0.256849564212391
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00342466	0.256849564212391
FAMILIAL CERVICAL ARTERY DISSECTION	0.00342466	0.256849564212391
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.256849564212391
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00342466	0.256849564212391
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00342466	0.256849564212391
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.256849564212391
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.00342466	0.256849564212391
APPARENT MINERALOCORTICOID EXCESS	0.00342466	0.256849564212391
ALAGILLE SYNDROME 2	0.00342466	0.256849564212391
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00342466	0.256849564212391
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00342466	0.256849564212391
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.256849564212391
NELSON SYNDROME	0.00342466	0.256849564212391
NAIL-PATELLA-LIKE RENAL DISEASE	0.00342466	0.256849564212391
NAIL-PATELLA SYNDROME	0.00342466	0.256849564212391
FRASIER SYNDROME	0.00342466	0.256849564212391
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.256849564212391
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.256849564212391
LONG QT SYNDROME 13; LQT13	0.00342466	0.256849564212391
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.256849564212391
SCALP-EAR-NIPPLE SYNDROME	0.00342466	0.256849564212391
CLASSIC HOMOCYSTINURIA	0.00342466	0.256849564212391
XQ21 MICRODELETION SYNDROME	0.00342466	0.256849564212391
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00342466	0.256849564212391
ARTERIAL TORTUOSITY SYNDROME	0.00342466	0.256849564212391
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00342466	0.256849564212391
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.256849564212391
NEPHRONOPHTHISIS 1	0.00342466	0.256849564212391
FAMILIAL BICUSPID AORTIC VALVE	0.00342466	0.256849564212391
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00342466	0.256849564212391
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00342466	0.256849564212391
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00342466	0.256849564212391
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.00342466	0.256849564212391
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00342466	0.256849564212391
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.00342466	0.256849564212391
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00342466	0.256849564212391
JOUBERT SYNDROME 14	0.00342466	0.256849564212391
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00342466	0.256849564212391
INFANT BOTULISM	0.00342466	0.256849564212391
CLASSICAL EHLERS-DANLOS SYNDROME	0.00342466	0.256849564212391
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.256849564212391
BUSCHKE-OLLENDORFF SYNDROME	0.00342466	0.256849564212391
HUNTER-MACDONALD SYNDROME	0.00342466	0.256849564212391
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.256849564212391
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00342466	0.256849564212391
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.256849564212391
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.00342466	0.256849564212391
STIFF SKIN SYNDROME	0.00342466	0.256849564212391
KEUTEL SYNDROME; KTLS	0.00342466	0.256849564212391
FAMILIAL DYSAUTONOMIA	0.00342466	0.256849564212391
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.256849564212391
SENIOR-LOKEN SYNDROME	0.00342466	0.256849564212391
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.256849564212391
GLYCOGEN STORAGE DISEASE IB	0.00342466	0.256849564212391
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.256849564212391
POLYCYSTIC KIDNEY DISEASE 3	0.00342466	0.256849564212391
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.256849564212391
XFE PROGEROID SYNDROME; XFEPS	0.00342466	0.256849564212391
SHWACHMAN-DIAMOND SYNDROME	0.00327869	0.24590181147545281
HOYERAAL-HREIDARSSON SYNDROME	0.00327869	0.24590181147545281
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00327869	0.24590181147545281
THYROCEREBRORENAL SYNDROME	0.00327869	0.24590181147545281
THROMBOCYTOPENIA 3	0.00327869	0.24590181147545281
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.00327869	0.24590181147545281
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00327869	0.24590181147545281
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00327869	0.24590181147545281
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00327869	0.24590181147545281
LIG4 SYNDROME	0.00327869	0.24590181147545281
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00327869	0.24590181147545281
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00327869	0.24590181147545281
THROMBOCYTOPENIA, CYCLIC	0.00327869	0.24590181147545281
THROMBOCYTOPENIA 2	0.00327869	0.24590181147545281
IMMUNE THROMBOCYTOPENIC PURPURA	0.00327869	0.24590181147545281
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.00327869	0.24590181147545281
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00327869	0.24590181147545281
IVIC SYNDROME	0.00327869	0.24590181147545281
SMITH-KINGSMORE SYNDROME; SKS	0.00327869	0.24590181147545281
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00327869	0.24590181147545281
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00327869	0.24590181147545281
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00327869	0.24590181147545281
STORMORKEN SYNDROME; STRMK	0.00327869	0.24590181147545281
THYROCEREBRORETINAL SYNDROME	0.00327869	0.24590181147545281
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00327869	0.24590181147545281
CERNUNNOS-XLF DEFICIENCY	0.00327869	0.24590181147545281
FECHTNER SYNDROME	0.00327869	0.24590181147545281
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00327869	0.24590181147545281
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00327869	0.24590181147545281
HERMANSKY-PUDLAK SYNDROME 9	0.00327869	0.24590181147545281
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00327869	0.24590181147545281
CONGENITAL TOXOPLASMOSIS	0.00327869	0.24590181147545281
TRANSCOBALAMIN DEFICIENCY	0.00327869	0.24590181147545281
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00327869	0.24590181147545281
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00327869	0.24590181147545281
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00327869	0.24590181147545281
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.00327869	0.24590181147545281
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00327869	0.24590181147545281
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00327869	0.24590181147545281
IDIOPATHIC APLASTIC ANEMIA	0.00327869	0.24590181147545281
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00327869	0.24590181147545281
WT LIMB-BLOOD SYNDROME	0.00327869	0.24590181147545281
TANGIER DISEASE	0.00327869	0.24590181147545281
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00327869	0.24590181147545281
PELGER-HUET ANOMALY; PHA	0.00327869	0.24590181147545281
PLATELET DISORDER, UNDEFINED	0.00327869	0.24590181147545281
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00327869	0.24590181147545281
CYCLIC NEUTROPENIA	0.00327869	0.24590181147545281
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00327869	0.24590181147545281
PLATELET SIGNAL PROCESSING DEFECT	0.00327869	0.24590181147545281
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00327869	0.24590181147545281
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00327869	0.24590181147545281
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00327869	0.24590181147545281
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00327869	0.24590181147545281
GOOD SYNDROME	0.00327869	0.24590181147545281
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00327869	0.24590181147545281
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00327869	0.24590181147545281
SEBASTIAN SYNDROME	0.00327869	0.24590181147545281
OSTEOGENESIS IMPERFECTA	0.00327869	0.24590181147545281
EOSINOPHILIA, FAMILIAL	0.00327869	0.24590181147545281
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00327869	0.24590181147545281
MONOSOMY 7 OF BONE MARROW	0.00327869	0.24590181147545281
FOLATE MALABSORPTION, HEREDITARY	0.00327869	0.24590181147545281
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00327869	0.24590181147545281
DK PHOCOMELIA SYNDROME	0.00327869	0.24590181147545281
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00327869	0.24590181147545281
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.00327869	0.24590181147545281
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00327869	0.24590181147545281
THROMBOCYTOPENIA 6	0.00327869	0.24590181147545281
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00327869	0.24590181147545281
FORSYTHE-WAKELING SYNDROME; FWS	0.00327869	0.24590181147545281
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00327869	0.24590181147545281
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.00327869	0.24590181147545281
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00327869	0.24590181147545281
DIAMOND-BLACKFAN ANEMIA 1	0.00327869	0.24590181147545281
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00327869	0.24590181147545281
SLC35A1-CDG	0.00327869	0.24590181147545281
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.00327869	0.24590181147545281
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.00327869	0.24590181147545281
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.24590181147545281
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00327869	0.24590181147545281
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00327869	0.24590181147545281
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00327869	0.24590181147545281
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00327869	0.24590181147545281
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00327869	0.24590181147545281
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00327869	0.24590181147545281
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00327869	0.24590181147545281
LATHOSTEROLOSIS	0.00327869	0.24590181147545281
FETAL PARVOVIRUS SYNDROME	0.00327869	0.24590181147545281
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00327869	0.24590181147545281
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00327869	0.24590181147545281
INSULIN-RESISTANCE SYNDROME TYPE B	0.00327869	0.24590181147545281
PSEUDO-TORCH SYNDROME 2	0.00327869	0.24590181147545281
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00327869	0.24590181147545281
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00327869	0.24590181147545281
SENGERS SYNDROME	0.00327869	0.24590181147545281
ACQUIRED PURPURA FULMINANS	0.00327869	0.24590181147545281
MIRAGE SYNDROME; MIRAGE	0.00327869	0.24590181147545281
THROMBOCYTOPENIA 5; THC5	0.00327869	0.24590181147545281
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00327869	0.24590181147545281
REFRACTORY ANEMIA	0.00327869	0.24590181147545281
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00327869	0.24590181147545281
STT3B-CDG	0.00327869	0.24590181147545281
IVIC SYNDROME	0.00327869	0.24590181147545281
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00327869	0.24590181147545281
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.00327869	0.24590181147545281
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00240964	0.18072304518076127
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00240964	0.18072304518076127
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00240964	0.18072304518076127
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00240964	0.18072304518076127
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00240964	0.18072304518076127
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00240964	0.18072304518076127
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00240964	0.18072304518076127
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00240964	0.18072304518076127
FAMILIAL MULTIPLE LIPOMATOSIS	0.00240964	0.18072304518076127
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00240964	0.18072304518076127
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00240964	0.18072304518076127
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00240964	0.18072304518076127
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00240964	0.18072304518076127
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00240964	0.18072304518076127
MATERNAL PHENYLKETONURIA	0.00240964	0.18072304518076127
XQ28 (MECP2) DUPLICATION	0.00240964	0.18072304518076127
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.00240964	0.18072304518076127
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00240964	0.18072304518076127
611961 STEVENSON-CAREY SYNDROME	0.00240964	0.18072304518076127
LISSENCEPHALY 8; LIS8	0.00240964	0.18072304518076127
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00240964	0.18072304518076127
FRONTOFACIONASAL DYSPLASIA	0.00240964	0.18072304518076127
HADZISELIMOVIC SYNDROME	0.00240964	0.18072304518076127
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00240964	0.18072304518076127
17P13.3 MICRODUPLICATION SYNDROME	0.00240964	0.18072304518076127
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00240964	0.18072304518076127
ANIRIDIA	0.00240964	0.18072304518076127
MECKEL SYNDROME, TYPE 4; MKS4	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00240964	0.18072304518076127
WARBURG MICRO SYNDROME 2; WARBM2	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00240964	0.18072304518076127
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00240964	0.18072304518076127
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00240964	0.18072304518076127
RETT SYNDROME, CONGENITAL VARIANT	0.00240964	0.18072304518076127
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00240964	0.18072304518076127
CEREBROOCULONASAL SYNDROME	0.00240964	0.18072304518076127
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.00240964	0.18072304518076127
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00240964	0.18072304518076127
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00240964	0.18072304518076127
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00240964	0.18072304518076127
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.00240964	0.18072304518076127
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00240964	0.18072304518076127
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00240964	0.18072304518076127
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00240964	0.18072304518076127
5Q14.3 MICRODELETION SYNDROME	0.00240964	0.18072304518076127
FRONTONASAL DYSPLASIA 2; FND2	0.00240964	0.18072304518076127
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00240964	0.18072304518076127
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00240964	0.18072304518076127
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00240964	0.18072304518076127
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00240964	0.18072304518076127
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00240964	0.18072304518076127
JOUBERT SYNDROME 31; JBTS31	0.00240964	0.18072304518076127
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00240964	0.18072304518076127
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00240964	0.18072304518076127
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00240964	0.18072304518076127
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00240964	0.18072304518076127
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00240964	0.18072304518076127
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00240964	0.18072304518076127
CHROMOSOME 13Q14 DELETION SYNDROME	0.00240964	0.18072304518076127
CODAS SYNDROME	0.00240964	0.18072304518076127
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00240964	0.18072304518076127
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00240964	0.18072304518076127
TYSHCHENKO SYNDROME	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00240964	0.18072304518076127
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.00240964	0.18072304518076127
CRANIOFRONTONASAL DYSPLASIA	0.00240964	0.18072304518076127
CRANIOFACIAL DYSSYNOSTOSIS	0.00240964	0.18072304518076127
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00240964	0.18072304518076127
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.00240964	0.18072304518076127
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00240964	0.18072304518076127
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00240964	0.18072304518076127
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00240964	0.18072304518076127
GLYCINE ENCEPHALOPATHY	0.00240964	0.18072304518076127
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.00240964	0.18072304518076127
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.00240964	0.18072304518076127
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00240964	0.18072304518076127
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00240964	0.18072304518076127
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00240964	0.18072304518076127
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00240964	0.18072304518076127
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00240964	0.18072304518076127
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00240964	0.18072304518076127
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00240964	0.18072304518076127
MEHMO SYNDROME; MEHMO	0.00240964	0.18072304518076127
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00240964	0.18072304518076127
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00240964	0.18072304518076127
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00240964	0.18072304518076127
ROIFMAN SYNDROME	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00240964	0.18072304518076127
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00240964	0.18072304518076127
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00240964	0.18072304518076127
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00240964	0.18072304518076127
MALAN OVERGROWTH SYNDROME	0.00240964	0.18072304518076127
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00240964	0.18072304518076127
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00240964	0.18072304518076127
XQ25 MICRODUPLICATION SYNDROME	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00240964	0.18072304518076127
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00240964	0.18072304518076127
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00240964	0.18072304518076127
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00240964	0.18072304518076127
XIA-GIBBS SYNDROME	0.00240964	0.18072304518076127
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.00240964	0.18072304518076127
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00240964	0.18072304518076127
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00240964	0.18072304518076127
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00240964	0.18072304518076127
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00240964	0.18072304518076127
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00240964	0.18072304518076127
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00240964	0.18072304518076127
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00240964	0.18072304518076127
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00240964	0.18072304518076127
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00240964	0.18072304518076127
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00240964	0.18072304518076127
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00240964	0.18072304518076127
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00240964	0.18072304518076127
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00240964	0.18072304518076127
WEBB-DATTANI SYNDROME; WEDAS	0.00240964	0.18072304518076127
COG2-CDG	0.00240964	0.18072304518076127
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00240964	0.18072304518076127
JOUBERT SYNDROME 21	0.00240964	0.18072304518076127
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00240964	0.18072304518076127
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00240964	0.18072304518076127
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00240964	0.18072304518076127
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00240964	0.18072304518076127
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00240964	0.18072304518076127
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00240964	0.18072304518076127
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00240964	0.18072304518076127
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00240964	0.18072304518076127
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00240964	0.18072304518076127
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00240964	0.18072304518076127
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00240964	0.18072304518076127
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00240964	0.18072304518076127
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00240964	0.18072304518076127
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00240964	0.18072304518076127
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00240964	0.18072304518076127
MENTAL RETARDATION, X-LINKED 102	0.00240964	0.18072304518076127
XQ25 DUPLICATION SYNDROME	0.00240964	0.18072304518076127
MENTAL RETARDATION, X-LINKED 104; MRX104	0.00240964	0.18072304518076127
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00240964	0.18072304518076127
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00240964	0.18072304518076127
PONTINE TEGMENTAL CAP DYSPLASIA	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00240964	0.18072304518076127
TURNPENNY-FRY SYNDROME; TPFS	0.00240964	0.18072304518076127
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00240964	0.18072304518076127
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00240964	0.18072304518076127
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00240964	0.18072304518076127
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00240964	0.18072304518076127
XQ12-Q13.3 DUPLICATION SYNDROME	0.00240964	0.18072304518076127
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00240964	0.18072304518076127
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00240964	0.18072304518076127
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00240964	0.18072304518076127
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00240964	0.18072304518076127
6Q TERMINAL DELETION SYNDROME	0.00240964	0.18072304518076127
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00240964	0.18072304518076127
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00240964	0.18072304518076127
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00240964	0.18072304518076127
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00240964	0.18072304518076127
BETA-THALASSEMIA ASSOCIATED WITH ANOTHER HEMOGLOBIN ANOMALY	0.00236407	0.17730529432632355
HEMOGLOBIN C-BETA-THALASSEMIA SYNDROME	0.00236407	0.17730529432632355
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.00236407	0.17730529432632355
SIALIDOSIS TYPE 1	0.00236407	0.17730529432632355
DOMINANT BETA-THALASSEMIA	0.00236407	0.17730529432632355
FAMILIAL TUMORAL CALCINOSIS	0.00236407	0.17730529432632355
SPHEROCYTOSIS, TYPE 1; SPH1	0.00236407	0.17730529432632355
BECKWITH-WIEDEMANN SYNDROME	0.00236407	0.17730529432632355
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00236407	0.17730529432632355
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00236407	0.17730529432632355
AREDYLD SYNDROME	0.00236407	0.17730529432632355
TAY-SACHS DISEASE	0.00236407	0.17730529432632355
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00236407	0.17730529432632355
PROTEUS-LIKE SYNDROME	0.00236407	0.17730529432632355
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.00236407	0.17730529432632355
FISH-EYE DISEASE	0.00236407	0.17730529432632355
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00236407	0.17730529432632355
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00236407	0.17730529432632355
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00236407	0.17730529432632355
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00236407	0.17730529432632355
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00236407	0.17730529432632355
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.00236407	0.17730529432632355
HYPERLIPOPROTEINEMIA, TYPE ID	0.00236407	0.17730529432632355
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00236407	0.17730529432632355
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00236407	0.17730529432632355
ROIFMAN SYNDROME; RFMN	0.00236407	0.17730529432632355
GLYCOPROTEIN STORAGE DISEASE	0.00236407	0.17730529432632355
GAUCHER DISEASE, TYPE IIIC	0.00236407	0.17730529432632355
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00236407	0.17730529432632355
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00236407	0.17730529432632355
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00236407	0.17730529432632355
HENNEKAM SYNDROME	0.00236407	0.17730529432632355
MULTIPLE MYELOMA	0.00236407	0.17730529432632355
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00236407	0.17730529432632355
CAMURATI-ENGELMANN DISEASE	0.00236407	0.17730529432632355
SANDHOFF DISEASE	0.00236407	0.17730529432632355
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00236407	0.17730529432632355
HEREDITARY OROTIC ACIDURIA	0.00236407	0.17730529432632355
SPHEROCYTOSIS, TYPE 2	0.00236407	0.17730529432632355
MEVALONIC ACIDURIA	0.00236407	0.17730529432632355
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00236407	0.17730529432632355
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00236407	0.17730529432632355
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00236407	0.17730529432632355
FREE SIALIC ACID STORAGE DISEASE	0.00236407	0.17730529432632355
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00236407	0.17730529432632355
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00236407	0.17730529432632355
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00236407	0.17730529432632355
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00236407	0.17730529432632355
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00236407	0.17730529432632355
PROTEUS SYNDROME	0.00236407	0.17730529432632355
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00236407	0.17730529432632355
ELLIPTOCYTOSIS 1; EL1	0.00236407	0.17730529432632355
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00236407	0.17730529432632355
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00236407	0.17730529432632355
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00236407	0.17730529432632355
CRONKHITE-CANADA SYNDROME	0.00236407	0.17730529432632355
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.00236407	0.17730529432632355
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00236407	0.17730529432632355
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00236407	0.17730529432632355
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00236407	0.17730529432632355
IMMUNODEFICIENCY 16	0.00236407	0.17730529432632355
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00236407	0.17730529432632355
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00236407	0.17730529432632355
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00236407	0.17730529432632355
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00236407	0.17730529432632355
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00236407	0.17730529432632355
PYCNODYSOSTOSIS	0.00236407	0.17730529432632355
INFANTILE SIALIC ACID STORAGE DISEASE	0.00236407	0.17730529432632355
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00236407	0.17730529432632355
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00236407	0.17730529432632355
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00236407	0.17730529432632355
MAST CELL SARCOMA	0.00236407	0.17730529432632355
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00236407	0.17730529432632355
HEMOGLOBIN--BETA LOCUS	0.00236407	0.17730529432632355
HURLER SYNDROME	0.00236407	0.17730529432632355
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00236407	0.17730529432632355
DK1-CDG	0.00236407	0.17730529432632355
CASPASE 8 DEFICIENCY	0.00236407	0.17730529432632355
LYMPHEDEMA, HEREDITARY, III	0.00236407	0.17730529432632355
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00236407	0.17730529432632355
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00236407	0.17730529432632355
SIALIDOSIS TYPE 2	0.00236407	0.17730529432632355
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00236407	0.17730529432632355
HB BART'S HYDROPS FETALIS	0.00236407	0.17730529432632355
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00236407	0.17730529432632355
PROTEUS SYNDROME	0.00236407	0.17730529432632355
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00236407	0.17730529432632355
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00236407	0.17730529432632355
OPSISMODYSPLASIA	0.00236407	0.17730529432632355
ESSENTIAL THROMBOCYTHEMIA	0.00236407	0.17730529432632355
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00236407	0.17730529432632355
APOLIPOPROTEIN C-II DEFICIENCY	0.00236407	0.17730529432632355
TANGIER DISEASE; TGD	0.00236407	0.17730529432632355
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00236407	0.17730529432632355
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00236407	0.17730529432632355
FARBER DISEASE	0.00236407	0.17730529432632355
MACROCEPHALY/AUTISM SYNDROME	0.00236407	0.17730529432632355
TYROSINEMIA TYPE 1	0.00236407	0.17730529432632355
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00236407	0.17730529432632355
X-LINKED SIDEROBLASTIC ANEMIA	0.00236407	0.17730529432632355
NIEMANN-PICK DISEASE, TYPE B	0.00236407	0.17730529432632355
NEPHRONOPHTHISIS 19; NPHP19	0.00236407	0.17730529432632355
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00236407	0.17730529432632355
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00236407	0.17730529432632355
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00236407	0.17730529432632355
FELTY SYNDROME	0.00236407	0.17730529432632355
IMMUNODEFICIENCY 36; IMD36	0.00236407	0.17730529432632355
MULTIPLE SULFATASE DEFICIENCY	0.00236407	0.17730529432632355
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00236407	0.17730529432632355
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00236407	0.17730529432632355
IMMUNODEFICIENCY 60; IMD60	0.00236407	0.17730529432632355
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00236407	0.17730529432632355
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.00236407	0.17730529432632355
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00236407	0.17730529432632355
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00236407	0.17730529432632355
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00236407	0.17730529432632355
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00236407	0.17730529432632355
PROLIDASE DEFICIENCY	0.00236407	0.17730529432632355
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00236407	0.17730529432632355
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00236407	0.17730529432632355
ALPHA-MANNOSIDOSIS	0.00236407	0.17730529432632355
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00236407	0.17730529432632355
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00236407	0.17730529432632355
8P11.2 DELETION SYNDROME	0.00236407	0.17730529432632355
FETAL CYTOMEGALOVIRUS SYNDROME	0.00236407	0.17730529432632355
NIEMANN-PICK DISEASE, TYPE C2	0.00236407	0.17730529432632355
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00236407	0.17730529432632355
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00236407	0.17730529432632355
REYNOLDS SYNDROME	0.00236407	0.17730529432632355
NIEMANN-PICK DISEASE TYPE C	0.00236407	0.17730529432632355
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.00236407	0.17730529432632355
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00236407	0.17730529432632355
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00236407	0.17730529432632355
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00236407	0.17730529432632355
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.00236407	0.17730529432632355
SCHEIE SYNDROME	0.00236407	0.17730529432632355
HURLER-SCHEIE SYNDROME	0.00236407	0.17730529432632355
SÉZARY SYNDROME	0.00236407	0.17730529432632355
NEURAMINIDASE DEFICIENCY	0.00236407	0.17730529432632355
ASPARTYLGLUCOSAMINURIA	0.00236407	0.17730529432632355
